-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TOMJEtKLXBd/mJrCPD3fMu7Ahv2FRw/I0y2yLxuda7a9dBdC2Imp6iOp+JPUUHSM XPWQxmAqp8HP+oPRzThd+w== 0000950149-00-000642.txt : 20000411 0000950149-00-000642.hdr.sgml : 20000411 ACCESSION NUMBER: 0000950149-00-000642 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 19991231 FILED AS OF DATE: 20000329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN SHARED HOSPITAL SERVICES CENTRAL INDEX KEY: 0000744825 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 942918118 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: SEC FILE NUMBER: 001-08789 FILM NUMBER: 581809 BUSINESS ADDRESS: STREET 1: TWO EMBARCADERO CENTER STREET 2: SUITE 2370 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-3823 BUSINESS PHONE: 4157885300 MAIL ADDRESS: STREET 1: 4 EMBARCADERO CENTER CITY: SAN FRANCISCO STATE: CA ZIP: 94111 10-K 1 AMERICAN SHARED HOSPITAL SERVICES FORM 10-K 1 - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ------------------------ FORM 10-K ------------------------ (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 1999 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ . COMMISSION FILE NUMBER 1-8789 ------------------------ AMERICAN SHARED HOSPITAL SERVICES (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) CALIFORNIA 94-2918118 (STATE OR OTHER JURISDICTION OF (IRS EMPLOYER INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
TWO EMBARCADERO CENTER, SUITE 2370, SAN FRANCISCO, CALIFORNIA 94111-3823 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (415) 788-5300 SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH REGISTERED ------------------- ----------------------------------------- Common Stock No Par Value American Stock Exchange Pacific Exchange
SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: NONE Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X] As of March 27, 2000, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $12,158,073. Number of shares of common stock of the registrant outstanding as of March 27, 2000: 3,810,042. DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant's definitive Proxy Statement for the 1999 Annual Meeting of its Shareholders are incorporated by reference into Part III of this report. - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 2 PART I ITEM 1. BUSINESS GENERAL American Shared Hospital Services ("ASHS" and, together with its subsidiaries, the "Company") currently provides Gamma Knife stereotactic radiosurgery services to eight medical centers in seven states. The Company provides these services through its 81% indirect interest in GK Financing, LLC, a California limited liability company ("GKF"). The remaining 19% of GKF is owned by GKV Investments, Inc., a wholly owned U.S. subsidiary of Elekta AG, a Swedish company ("Elekta"). Elekta is the manufacturer of the Leksell Gamma Knife (the "Gamma Knife"). GKF is a non-exclusive provider of alternative financing services for Elekta. Gamma Knife services accounted for almost 100% of the Company's revenues in 1999. At present, the Company is developing a business plan for "The Operating Room for the 21st Century" (sm) ("OR21" (sm)). The Company also is exploring Internet-related business opportunities that relate strategically and operationally to its existing and developing lines of business. Neither OR21 nor the Internet-related businesses are expected to generate significant revenues within the next twelve months. The Company's former insurance services business did not contribute significant revenues and was discontinued during second quarter 1999. During November 1998, the Company sold its diagnostic imaging business to affiliates of Alliance Imaging, Inc. (the "Purchaser") for $13,552,000 in cash and the assumption by the Purchaser of substantially all of the liabilities of the diagnostic imaging business, including approximately $27.1 million in debt and other liabilities. Prior to that sale, the Company provided Magnetic Resonance Imaging ("MRI"), Computed Axial Tomography ("CT"), Ultrasound, Nuclear Medicine and Cardiac Catheterization Laboratory services to approximately 190 customers in 22 states. The diagnostic imaging business provided approximately 88% and 94%, respectively, of the Company's revenues for the years ended December 31, 1998 and 1997. The Company was incorporated in the state of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. GAMMA KNIFE OPERATIONS Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery. Compared to conventional surgery, Gamma Knife surgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their normal activities one or two days after treatment. The Gamma Knife treats the patient with 201 single doses of gamma rays that are focused with great precision on small, well circumscribed and critically located structures in the brain. The Gamma Knife delivers the concentrated dose of gamma rays from 201 sources of Cobalt 60 housed in the Gamma Knife. The 201 Cobalt 60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected benign brain tumors (i.e. meningiomas, pituitary and acoustic neuromas, craniopharyngiomas), malignant tumors (i.e. gliomas, nasopharyngeal carcinomas, ocular meningiomas and solitary and multiple metastatic tumors), arteriovenous malformations and trigeminal neuralgia (facial pain). Research is being conducted in the treatment of Parkinson's Disease, epilepsy, and other functional disorders. There currently are 55 Gamma Knife units operating at 54 sites in the United States and approximately 135 units worldwide. As of December 31, 1999, approximately 135,000 procedures had been performed worldwide. An estimated percentage breakdown of these Gamma Knife procedures performed in the U.S. by indications treated are as follows: malignant (40%) and benign (32%) tumors, vascular disorders (17%) and functional disorders (11%). The Company currently has eight (8) Gamma Knife units operating at eight (8) sites in the United States. In addition, the Company has signed agreements with four (4) more hospitals that are currently under development or construction, plus two (2) signed contracts that are subject to state regulatory approval. The 2 3 Company's first Gamma Knife commenced operation in September 1991. The Company's Gamma Knife units had performed approximately 3,300 procedures through December 31, 1999. Gamma Knife revenues for the Company during the five (5) years ended December 31, 1999, and the percentage of total revenues of the Company represented by the Gamma Knife for each of the last five years are set forth below:
YEAR ENDED TOTAL GAMMA KNIFE GAMMA KNIFE/ DECEMBER 31, REVENUES (IN THOUSANDS) TOTAL REVENUES ------------ ----------------------- -------------- 1999.................................... $7,151 99.9% 1998.................................... $4,156 11.8% 1997.................................... $2,384 6.4% 1996.................................... $2,030 5.5% 1995.................................... $1,325 3.9%
The Company conducts its Gamma Knife business through its 81% indirect interest in GKF. The remaining 19% interest is indirectly owned by Elekta. GKF, a limited liability company, was formed in October 1995. GKF is managed by its policy committee. The policy committee is composed of one representative from the Company, Ernest A. Bates, M.D., and one representative from Elekta. The policy committee sets the operating policy for GKF. The policy committee may act only with the unanimous approval of all of its members. The policy committee selects a manager to handle GKF's daily operations. Craig K. Tagawa, Chief Executive Officer of GKF and Chief Operating and Financial Officer of the Company, serves as GKF's manager. GKF profits and/or losses and any cash distributions are allocated based on membership interests. GKF's Operating Agreement requires that it have a cash reserve of at least $50,000 prior to cash distributions to its members. From inception to December 31, 1999, GKF had distributed $1,558,000 to the Company. RISKS OF GAMMA KNIFE BUSINESS There are significant risks involved in the Company's Gamma Knife business, including the following: - Each Gamma Knife unit requires a substantial capital investment. The Company's cost for a Gamma Knife unit historically has been approximately $2,750,000. In some cases, the Company contributes additional funds for capital costs and/or annual operating costs such as marketing. Due to the structure of its contracts with medical centers, there can be no assurance that these costs will be fully recovered or that the Company will earn a satisfactory return on its investment. - There is a limited market for the Gamma Knife. Due to the substantial costs of acquiring a Gamma Knife, the Company must identify medical centers that possess neurosurgery and oncology departments capable of performing a large number of Gamma Knife procedures. The Company has identified approximately 200 such medical centers in the United States as potential future sites. There currently are 55 operating Gamma Knife units in the United States, eight (8) of which are Company-operated units. There can be no assurance that the Company will be successful in placing additional units at a significant number of sites in the future. - There currently are four companies (in addition to the Company) that supply the Gamma Knife to potential customers. One of the four companies purchased one Gamma Knife within the last twelve months. The Company does not currently have an exclusive relationship with Elekta and has lost sales in the past to customers that choose to purchase a Gamma Knife directly from Elekta. In addition, the Company may continue to lose sales in the future to such customers and may also lose sales to competitors of the Company. There can be no assurance that the Company will be able to successfully compete against others to place units in the future. - There are several methods of radiosurgery (including the modified linear accelerator) as well as conventional neurosurgery that compete against the Gamma Knife. Currently, there are approximately 200 medical centers in the United States with modified linear accelerators. Each of the medical centers targeted by the Company could decide to acquire another radiosurgery modality instead of a Gamma Knife. In addition, neurosurgeons who are primarily responsible for referring patients for Gamma Knife surgery may not be willing to make such referrals for various reasons, instead opting for invasive 3 4 surgery. There can be no assurance that the Company will be able to secure a sufficient number of sites or Gamma Knife procedures to attain profitability and growth. - The amount reimbursed to medical centers for each Gamma Knife treatment may decline in the future. The reimbursement decrease may come from federally mandated programs (i.e. Medicare and Medicaid) and other third party payor groups. A significant amount of the Company's existing contracts are reimbursed by the medical center to the Company on a fee-for-service basis. The primary risk to the Company under this type of contract is that actual volumes of procedures could be less than projected. The Company also has two contracts where it receives revenues based directly on the amount of reimbursement received for procedures performed. Revenues under those contracts and any future contracts with revenue based directly on reimbursement amounts will be impacted by any reimbursement rate change. Some of the Company's future contracts for Gamma Knife services may have revenues based on such reimbursement rates instead of a fee-for-service basis. There can be no assurance that future changes in healthcare regulations and reimbursement rates will not adversely affect the Company's Gamma Knife revenues. - As with other highly sophisticated medical equipment, there is constant change and innovation in the market. New and improved medical equipment can be introduced that could make the Gamma Knife technology obsolete and that would make its operation uneconomic. During the current year, Elekta is introducing an upgraded Gamma Knife which is expected to cost approximately $3.4 million plus applicable tax and duties. This upgrade is anticipated to automate the patient positioning process and therefore involve less health care provider intervention. Seven (7) of the Company's existing Gamma Knife units are upgradeable. The cost to upgrade existing units to the new model is estimated to be up to $900,000. CUSTOMERS The Company's current business is the outsourcing of Gamma Knife stereotactic radiosurgery services. The Company typically provides the Gamma Knife equipment, as well as planning, installation and marketing support services. Customers usually pay the Company on a fee-per-use basis. The market for these services primarily consists of major urban medical centers. The Gamma Knife business is capital intensive. The total cost of a Gamma Knife facility usually ranges from $3.25 million to $4 million, including equipment, site construction and installation. The Company's typical, historical costs for acquisition are approximately $2,750,000 with the medical center paying for site and installation costs.
CUSTOMER ORIGINAL TERM OF CONTRACT BASIS OF PAYMENT -------- ------------------------- ----------------- EXISTING SITES UCSF-Stanford Health Care ( "UCSF") San Francisco, California...................... 10 years Fee per use Hoag Memorial Hospital Presbyterian ("Hoag") Newport Beach, California...................... 10 years Fee per use Southwest Texas Methodist Hospital ("STMH") San Antonio, Texas................................. 10 years Fee per use Yale New Haven Ambulatory Services Corporation ("Yale") New Haven, Connecticut................ 10 years Revenue sharing Kettering Medical Center ("Kettering") Kettering, Ohio................................ 10 years Fee per use New England Medical Center ("NEMC") Boston, Massachusetts.................................. 10 years Fee per use University of Arkansas for Medical Sciences ("UAMS") Little Rock, Arkansas................. 15 years Revenue sharing Froedtert Memorial Lutheran Hospital ("FMLH") Milwaukee, Wisconsin........................... 10 years Fee per use SITES UNDER DEVELOPMENT JFK Medical Center Edison, New Jersey............................. 10 years Fee per use Sunrise Hospital and Medical Center Las Vegas, Nevada.............................. 10 years Fee per use
4 5
CUSTOMER ORIGINAL TERM OF CONTRACT BASIS OF PAYMENT -------- ------------------------- ----------------- Clinica San Felipe Lima, Peru..................................... 10 years Revenue Sharing Hospital Barra D'Or Rio de Janeiro, Brazil......................... 10 years Fee per use SIGNED, PENDING STATE REGULATORY APPROVAL
Two additional contracts are signed, pending state regulatory approval. The Company's second Gamma Knife contract, with the University of Southern California ("USC") ended in third quarter 1999. The customer exercised its option to purchase the equipment for its net book value, approximately $1.2 million. Currently, one of the Company's sites now under development is projected to become operational in second quarter 2000, and two additional contracts are expected to become operational in fourth quarter 2000. The Company's contract with Hospital Barra D'Or currently is being renegotiated with the customer in light of the changes in the Brazilian economic environment. If the contract cannot be successfully renegotiated, it will be terminated. The projected operational dates for contracts pending state regulatory approval cannot currently be estimated. The Company's fee per use agreement is typically for a ten-year term. The fixed fee per use reimbursement amount that the Company receives from the customer is based on the Company's cost to provide the service and the anticipated volumes of the customer. The contracts signed by the Company typically call for a fee ranging from $7,500 to $9,500 per procedure. There are no minimum volume guarantees required of the customer. Typically, GKF is responsible for providing the Gamma Knife and related ongoing Gamma Knife equipment expenses (i.e. personal property taxes, insurance, equipment maintenance) and also helps fund the customer's Gamma Knife marketing. Typically, the customer is obligated to pay site and installation costs and the costs of operating the Gamma Knife. Generally, the customer can either renew the agreement or terminate the agreement upon the termination date of the agreement. If the customer chooses to terminate the agreement, then GKF removes the equipment from the medical center. The Company's revenue sharing agreements are typically for a period of ten to fifteen years. Instead of receiving a fixed fee, the company receives all or a percentage of the reimbursement (exclusive of physician fees) received by the customer less the operating expenses of the Gamma Knife. The Company is at risk for any reimbursement rate changes for Gamma Knife services by third party payors. The Company is also at risk if it inefficiently operates its Gamma Knife services. There are no minimum volume guarantees required of the customer. Four customers each accounted for more than 10% of the Company's revenues in 1999: USC, Hoag, STMH and Yale. No single customer accounted for 10% or more of the Company's total revenues in 1998 or 1997, but each of the five Gamma Knife customers in 1998 and each of the three Gamma Knife customers in 1997 accounted for more than 10% of the Company's Gamma Knife services revenues in those years of operation. MARKETING At the end of 1999, the Company employed one sales executive. The Company markets its services through its preferred provider status with Elekta and a direct sales effort. The major advantages to a health care provider in contracting with the Company for Gamma Knife services include: - The medical center avoids the high cost of owning the equipment. By not acquiring the Gamma Knife unit, the medical center is able to allocate the funds required to purchase and/or finance the Gamma Knife to other projects. - The medical center avoids the risk of Gamma Knife under-utilization. The Company does not have minimum volume requirements. The medical center pays the Company only for each Gamma Knife procedure performed on a patient. - The medical center transfers the risk of technological obsolescence to the Company. The medical center and its physicians are not under any obligation to utilize technologically obsolete equipment. - The Company provides planning, installation, operating and marketing assistance and support to its Gamma Knife customers. 5 6 FINANCING The Company's Gamma Knife business is operated through GKF. GKF has funded its existing Gamma Knife units with loans from a single lender for 100% of the cost of each Gamma Knife, plus any sales tax, customs and duties. The loans are fully amortized over an 84-month period. The loans are collateralized by the Gamma Knife, customer contracts, and accounts receivable and are without recourse to the Company and Elekta. GKF currently has loan commitments and has received progress payments from its primary lender for two (2) of its four (4) Gamma Knife projects under development. The loan commitments require that GKF have a debt to equity plus subordinated debt ratio of 6 to 1. GKF currently meets the ratio requirement to be eligible for funding of the approximately $6,500,000 remaining cash requirements for its four (4) projects under development. COMPETITION Conventional neurosurgery is the primary competitor of Gamma Knife radiosurgery. Gamma Knife surgery is gaining acceptance as an alternative and/or adjunct to conventional surgery due to its more favorable morbidity outcomes for certain procedures as well as its non-invasiveness. Utilization of the Company's Gamma Knife units is contingent on the acceptance of Gamma Knife radiosurgery by the customer's neurosurgeons, radiation oncologists and referring physicians. In addition, the utilization of the Company's Gamma Knife units is impacted by the proximity of competing Gamma Knife centers and providers using other radiosurgery modalities. The Company's ability to contract with additional customers for Gamma Knife services is dependent on its ability to compete against (i) other companies that outsource Gamma Knife services, (ii) Elekta, the manufacturer of the Gamma Knife, and (iii) manufacturers of competing radiosurgery devices (primarily modified linear accelerators). The Company does not have an exclusive relationship with Elekta and has lost sales in the past to customers that choose to purchase a Gamma Knife directly from Elekta. The Company may continue to lose sales in the future to such customers and may also lose sales to competitors of the Company. GOVERNMENT REGULATION The Company's Gamma Knife services customers receive payments for patient care from federal government and private insurer reimbursement programs. Currently, Gamma Knife services are performed primarily on an in-patient basis, although a significant number are performed on an outpatient basis. A Prospective Payment System ("PPS") is utilized to reimburse hospitals for care given to hospital in-patients covered by federally funded reimbursement programs. Patients are classified into a Diagnosis Related Group ("DRG") in accordance with the patient's diagnosis, necessary medical procedures and other factors. Patient reimbursement is limited to a predetermined amount for each DRG. The reimbursement payment may not necessarily cover the cost of all medical services actually provided because the payment is predetermined. Effective October 1, 1997, Gamma Knife services for Medicare hospital in-patients were reclassified from DRG 1 to either DRG 7 or DRG 8. This reclassification is estimated to have reduced medical center revenues from the Medicare DRG program by approximately 30%. In the future, this reduction may lower reimbursement from other third party payors. In 1986 and again in 1990, Congress enacted legislation requiring the Department of Health and Human Services ("DHHS") to develop proposals for a PPS for hospital outpatient services. DHHS has proposed a new payment system, Ambulatory Product Classifications ("APC"), which affects all outpatient services, including those performed in a hospital based or free-standing facility. APC implementation is anticipated in the third or fourth quarter 2000. The APC consist of 346 clinically, homogenous classifications or groupings of codes that are typically used in outpatient billing. Outpatient services will be bundled with fixed rates of payment determined according to specific regional and national factors, similar to that of the in-patient PPS. Overall, the system is expected to reduce payments for select services and encourage the most efficient use of resources for outpatient care. 6 7 The current APC proposal categorizes radiosurgery under conventional radiation therapy. Therefore, both procedures would receive the same reimbursement amounts. This categorization makes no distinction with regard to the types of resources utilized (e.g. technology) for each procedure classification. Therefore, regardless of resource consumption and clinical outcomes, all procedures within a group qualify for equal reimbursement. Specifically, stereotactic radiosurgery would receive the same reimbursement per session as conventional radiation therapy. This would result in a significant reimbursement decrease for Gamma Knife patients covered by Medicare treated on an outpatient basis. Various groups have informed DHHS of the discrepancies of these service levels in an attempt to be compensated in line with the intent of the APC system. It is not the intent of the APC system to compensate providers similarly for clinically different procedures. The APC reimbursement amount is not known at this time. The Company has two contracts where the revenue is directly affected by changes in payment rates by Medicare and other third party payors. Some of GKF's future contracts for Gamma Knife services may be on a similar reimbursement-sensitive basis instead of a fee-for-service basis. As a result of lower reimbursement rates, profitability from future contracts will be reduced unless the number of Gamma Knife procedures can be increased or if the costs to provide Gamma Knife services can be lowered. The payment of remuneration to induce the referral of health care business has been a subject of increasing governmental and regulatory focus in recent years. Section 1128B(b) of the Social Security Act (sometimes referred to as the "federal anti-kickback statute") provides criminal penalties for individuals or entities that knowingly and willfully offer, pay, solicit or receive remuneration in order to induce referrals for items or services for which payment may be made under the Medicare and Medicaid programs and certain other government funded programs. The Social Security Act provides authority to the Office of Inspector General through civil proceedings to exclude an individual or entity from participation in the Medicare and state health programs if it is determined any such party has violated Section 1128B(b) of the Social Security Act. The Company believes that it is in compliance with the federal anti-kickback statute. Additionally, the Omnibus Budget Reconciliation Act of 1993, often referred to as "Stark II", bans physician self-referrals to providers of designated health services with which the physician has a financial relationship. The term "designated health services" includes, among others, radiation therapy services and in-patient and outpatient hospital services. On January 1, 1995, the Physician Ownership and Referral Act of 1993 became effective in California. This legislation prohibits physician self-referrals for covered goods and services, including radiation oncology, if the physician (or the physician's immediate family) concurrently has a financial interest in the entity receiving the referral. The Company believes that it is in compliance with these rules and regulations. A range of federal civil and criminal laws target false claims and fraudulent billing activities. One of the most significant is the Federal False Claims Act, which prohibits the submission of a false claim or the making of a false record or statement in order to secure a reimbursement from a government-sponsored program. In recent years, the federal government has launched several initiatives aimed at uncovering practices which violate false claims or fraudulent billing laws. Claims under these laws may be brought either by the government or by private individuals on behalf of the government, through a "whistleblower" or "qui tam" action. The Company believes that it is in compliance with the Federal False Claims Act; however, because such actions are filed under seal and may remain secret for years, there can be no assurance that the Company or one of its affiliates is not named in a material qui tam action. Legislation in various jurisdictions requires that health facilities obtain a Certificate of Need ("CON") prior to making expenditures for medical technology in excess of specified amounts. One of the Company's existing customers was required to obtain a CON. Two more of the Company's more recently-signed contracts are subject to CONs. The CON procedure can be expensive and time consuming and may impact the length of time before Gamma Knife services commence. CON requirements vary from state to state in their application to the operations of both the Company and its customers. In some jurisdictions the Company is required to comply with CON procedures to provide its services and in other jurisdictions customers must comply with CON procedures before using the Company's services. The Company's Gamma Knife units contain Cobalt 60 radioactive sources. The medical centers that house the Company's Gamma Knife units are responsible for obtaining possession and user's licenses for the Cobalt 60 source. The Company believes it is in substantial compliance with the various rules and regulations that affect its businesses. 7 8 INSURANCE AND INDEMNIFICATION The Company's contracts with equipment vendors generally do not contain indemnification provisions. The Company maintains a comprehensive insurance program covering the value of its property and equipment, subject to deductibles, which the Company believes are reasonable. The Company's customer contracts generally contain mutual indemnification provisions. The Company maintains general and professional liability insurance. The Company is not involved in the practice of medicine and therefore believes its present insurance coverage and indemnification agreements are adequate for its business. EMPLOYEES At December 31, 1999, the Company employed eight (8) employees on a full-time basis. None of these employees is subject to a collective bargaining agreement and there is no union representation within the Company. The Company maintains various employee benefit plans and believes that its employee relations are good. EXECUTIVE OFFICERS OF THE COMPANY The following table provides current information concerning those persons who serve as executive officers of the Company. The executive officers were appointed by the Board of Directors and serve at the discretion of the Board of Directors.
NAME: AGE: POSITION: ----- ---- --------- Ernest A. Bates, M.D. 63 Chairman of the Board of Directors, Chief Executive Officer Craig K. Tagawa 46 Senior Vice President -- Chief Operating and Financial Officer Richard Magary 59 Senior Vice President -- Administration, Assistant Secretary Gregory Pape 44 Senior Vice President -- Sales and Marketing
ERNEST A. BATES, M.D., founder of the Company, has served in the positions listed above since the incorporation of the Company, except for the periods May 1, 1991 through November 6, 1992 and February 1989 through August 1989, during which time Dr. Bates did not serve in the capacity of President and Chief Operating Officer. Dr. Bates is a graduate of The Johns Hopkins University and the University of Rochester School of Medicine. He is currently an Assistant Clinical Professor of Neurosurgery at the University of California Medical Center at San Francisco, and a member of the Board of Trustees of The Johns Hopkins University and the University of Rochester, a Director of the Industrial Policy Advisory Committee of the Engineering Research Center for Computer-Integrated Surgical Systems and Technology ("CISST") at The Johns Hopkins University, a Member of the State of California High Speed Rail Authority, and a Member of the Board of Directors of Salzburg Seminar. CRAIG K. TAGAWA has served as Chief Operating Officer since February 1999 in addition to serving as Chief Financial Officer since May 1996. Mr. Tagawa also served as Chief Financial Officer from January 1992 through October 1995. Previously a Vice President in such capacity, Mr. Tagawa became a Senior Vice President on February 28, 1993. He is also the Chief Executive Officer of GK Financing, LLC. From September 1988 through January 1992, Mr. Tagawa served in various positions with the Company. From 1982 through August 1988, Mr. Tagawa served as Vice President of Finance and Controller of Medical Ambulatory Care, Inc., the Dialysis division of National Medical Enterprises, Inc. (now Tenet Healthcare Corporation), an owner and operator of hospitals and other health care businesses. Mr. Tagawa received his Undergraduate degree from the University of California at Berkeley and his M.B.A from Cornell University. RICHARD MAGARY has served as Senior Vice President -- Corporate Development or Administration since February 28, 1993 and as Assistant Secretary since 1985. Mr. Magary will conclude his current duties in May of 2000 and become an advisor to the Company. From April 1987 through February 1993, Mr. Magary served as a Vice President in the same capacity as his current duties. From 1982 through March 1987, he 8 9 served as Chief Financial Officer of the Company and its predecessor. Mr. Magary is a graduate of the University of San Francisco. GREGORY PAPE has served as Senior Vice President -- Sales and Marketing since June 1994. From January 1993 through June 1994, Mr. Pape was a Zone Vice President -- Sales and Marketing for the Company. Mr. Pape served in the capacity of Regional Sales Manager for the Company for the period from March 1991 through January 1993. From September 1989 through February 1991, Mr. Pape was a Regional Sales Manager for Medical Imaging Corporation of America, Inc. Mr. Pape earned his undergraduate degree at the University of Miami, Florida with postgraduate work in law at the University of Dayton, Ohio. ITEM 2. PROPERTIES The Company's corporate offices are located at Two Embarcadero Center, Suite 2370, San Francisco, California, where it leases approximately 2,550 square feet for $11,208 per month. This lease runs through September 2002. For the year ended December 31, 1999 the Company's aggregate net rental expenses for all properties and equipment were approximately $117,000. ITEM 3. LEGAL PROCEEDINGS There are no material pending legal proceedings involving the Company or any of its property. The Company knows of no legal or administrative proceedings against the Company contemplated by governmental authorities. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None. PART II ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS The Company's common shares, no par value (the "Common Shares"), are currently traded on the American Stock Exchange ("AMEX") and the Pacific Exchange ("PCX"). The table below sets forth the high and low closing sales prices of the Common Shares of the Company on the American Stock Exchange Consolidated Reporting System for each full quarter for the last two fiscal years. PRICES FOR COMMON SHARES
QUARTER ENDING HIGH LOW -------------- ---- --- March 31, 1998............................................. 1 15/16 1 3/8 June 30, 1998.............................................. 1 7/8 1 1/4 September 30, 1998......................................... 1 1/4 5/8 December 31, 1998.......................................... 1 1/4 5/8 March 31, 1999............................................. 1 11/16 15/16 June 30, 1999.............................................. 3 1 1/2 September 30, 1999......................................... 6 1/4 2 3/8 December 31, 1999.......................................... 5 3/8 3 7/16
The Company estimates that there were approximately 1,400 beneficial holders of its Common Shares as of December 31, 1999. The Company's Board of Directors authorized, and the Company completed in March 1999 the repurchase of all of its remaining securities owned by two major holders who acquired them in the Company's 1995 financial restructuring. The repurchases were made directly from the holders. The repurchased securities included shares of the Company's Common Stock, and Warrants to acquire additional shares of Common Stock. The repurchased securities represented approximately 12.6% of the 9 10 Company's then-issued and outstanding common shares and about 12.6% of its then-fully diluted outstanding shares. The aggregate repurchase price paid by the Company was approximately $702,000. The Board of Directors also authorized in March 1999 the repurchase of up to 500,000 additional shares of the Company's Common Stock in the open market from time to time at prevailing prices. Approximately 196,000 shares were repurchased in the open market pursuant to that authorization, through December 31, 1999, at a cost of approximately $498,000. During 1999 holders of warrants and of options to acquire the Company's common stock exercised their respective rights pursuant to such securities, resulting in the Company issuing approximately 37,000 new shares of its common stock, in exchange for payments totaling approximately $37,000. On March 22, 1999, the Company adopted a Shareholder Rights Plan ("Plan"). Under the Plan, the Company made a dividend distribution of one Right for each outstanding share of the Company's common stock as of the close of business on April 1, 1999. The Rights become exercisable only if any person or group, with certain exceptions, becomes an "acquiring person" (acquires 15 percent or more of the Company's outstanding common stock) or announces a tender or exchange offer to acquire 15 percent or more of the Company's outstanding common stock. The Company's Board of Directors adopted the Plan to protect shareholders against a coercive or inadequate takeover offer. The Board of Directors is not aware that any person or group intends to make a takeover offer for the Company. Following the transactions described above, as of December 31, 1999 the Company had 5,732,964 fully diluted shares outstanding, including 3,813,042 issued and outstanding common shares, 1,370 common shares reserved for warrants, 1,912,867 common shares reserved for options, and 5,685 shares reserved pursuant to the Company's Shareholder Rights Plan. The Company did not pay cash dividends in 1999 and does not anticipate paying cash dividends in 2000. 10 11 ITEM 6. SELECTED FINANCIAL DATA SUMMARY OF OPERATIONS
YEAR ENDED DECEMBER 31, -------------------------------------------------- 1999 1998 1997 1996 1995(1) ------- ------- ------- -------- -------- (AMOUNTS IN THOUSANDS EXCEPT PER SHARE DATA) Medical services revenues.................... $ 7,156 $35,162 $37,172 $ 36,989 $ 34,077 ======= ======= ======= ======== ======== Costs of operations.......................... 2,165 25,826 27,044 28,071 32,675 Selling and administrative expense........... 1,803 5,116 5,901 5,309 8,432 Interest expense............................. 1,309 3,186 3,671 4,199 5,310 Write-down of intangible assets.............. 0 0 0 0 600 ------- ------- ------- -------- -------- Total costs and expenses..................... 5,277 34,128 36,616 37,579 47,017 ------- ------- ------- -------- -------- 1,879 1,034 556 (590) (12,940) (Loss) gain on sale of assets and early termination of capital leases.............. 10 (2) 821 3 226 Gain on disposal of product line............. 0 20,478 0 0 0 Interest and other income.................... 603 220 118 170 258 Minority interest............................ (501) (166) 37 57 0 ------- ------- ------- -------- -------- Income (loss) before income taxes and extraordinary item......................... 1,991 21,564 1,532 (360) (12,456) Income tax benefit (expense)................. 716 (1,513) (10) 7 (3) ------- ------- ------- -------- -------- Income (loss) before extraordinary item...... 2,707 20,051 1,522 (353) (12,549) Extraordinary item........................... 0 0 0 0 19,803 ------- ------- ------- -------- -------- Net income (loss)............................ $ 2,707 $20,051 $ 1,522 $ (353) $ 7,344 ======= ======= ======= ======== ======== Earnings (loss) per common share: Income (loss) before extraordinary item.................................. $ 0.68 $ 4.23 $ 0.32 $ (0.08) $ (2.96) Extraordinary item...................... $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 4.71 ------- ------- ------- -------- -------- Net income (loss)....................... $ 0.68 $ 4.23 $ 0.32 $ (0.08) $ 1.75 ======= ======= ======= ======== ======== Earnings (loss) per common share assuming dilution: Income (loss) before extraordinary item.................................. $ 0.48 $ 3.15 $ 0.24 $ (0.08) $ (2.96) Extraordinary item...................... $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 4.71 ------- ------- ------- -------- -------- Net income (loss)....................... $ 0.48 $ 3.15 $ 0.24 $ (0.08) $ 1.75 ======= ======= ======= ======== ======== BALANCE SHEET DATA Cash......................................... $12,903 $11,114 $ 17 $ 368 $ 452 Restricted Cash.............................. 50 2,226 651 218 493 Working capital (deficiency)................. 11,125 9,088 (8,039) (10,888) (6,793) Total assets................................. 36,986 26,919 30,209 32,969 31,335 Current portion of long-term debt............ 2,545 1,885 10,929 13,182 8,720 Long-term debt, less current portion......... 19,887 8,823 21,569 23,935 26,125 Senior subordinated notes.................... 0 0 0 0 773 Shareholders' equity (Net capital deficiency)................................ $12,639 $11,096 $(8,953) $(10,475) $(10,576)
See accompanying note - --------------- (1) In June 1995, ASHS incorporated a new wholly-owned subsidiary, African American Church Health and Economic Services, Inc. ("ACHES") and ACHES' wholly-owned subsidiary, ACHES Insurance Services, Inc. ("AIS"), and in October 1995, entered into an operating agreement granting to American Shared Radiosurgery Services (a California corporation and a wholly-owned subsidiary of the Company) an 81% ownership interest in GK Financing, LLC. Accordingly, the financial data for the Company presented above include the results of the establishment of ACHES, AIS, and GK Financing, LLC for 1995 through 1999. 11 12 ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS GENERAL During the years ended December 31, 1999, 1998 and 1997, approximately 100%, 12% and 6% respectively, of the Company's revenues were derived from its Gamma Knife business. The Company in November 1998 sold its diagnostic imaging business which accounted for 0%, 88% and 94% of the Company's total revenues during the years ended December 31, 1999, 1998 and 1997, respectively. As a result, the Company was relieved of substantially all of the liabilities of the imaging division, consisting of approximately $27,100,000 of debt and other obligations, and received approximately $13,500,000 in cash. The sale of its imaging division resulted in a one-time gain of $20,478,000 in 1998, which eliminated the Company's capital deficiency. Following the sale, the Company's operations were significantly reduced and it has substantially reduced its staff. Accordingly the discussions below related to 1998 and 1997 predominantly reflect the Company's operations prior to the sale of its imaging division. The Company had net income of $2,707,000 ($0.68 per share) on medical services revenues of $7,156,000 in 1999. Net income in 1999 included an insurance expense credit of $325,000 and an income tax benefit of $716,000. The Company had net income of $20,051,000 ($4.23 per share) on medical services revenues of $35,162,000 in 1998. Included in net income for 1998 is a $20,478,000 gain on disposal of product line less Sale-related income taxes of $1,500,000. TOTAL REVENUES
INCREASE INCREASE 1999 (DECREASE) 1998 (DECREASE) 1997 ------ ---------- ------- ---------- ------- (IN THOUSANDS) Medical services................................ $7,156 (79.6%) $35,162 (5.4%) $37,172
Medical services revenues decreased 79.6% in 1999 compared to 1998, and decreased 5.4% in 1998 compared to 1997. Both decreases are primarily attributable to the sale of the Company's imaging division, which occurred in November 1998. Gamma Knife revenues increased $2,995,000 and $1,772,000 in 1999 and 1998, respectively, compared to the prior years. The 1999 increase was primarily due to the commencement of four new Gamma Knife contracts during 1999 and full year inclusion of the Company's fourth and fifth Gamma Knife units. The Company's sixth Gamma Knife commenced operation in second quarter 1999, the seventh and eighth commenced operation during third quarter 1999, and the ninth commenced operation in late fourth quarter 1999. The Company's second Gamma Knife contract expired during fourth quarter 1999 leaving a net of eight Gamma Knife units in operation at December 31, 1999. The customer purchased the Gamma Knife after the expiration of the contract for $1,200,000 in cash in November 1999. The 1998 increase vs. 1997 was primarily due to the commencement of the Company's fourth Gamma Knife in March 1998 and the fifth Gamma Knife in July 1998, and full year inclusion of the Company's third Gamma Knife unit. MRI revenues decreased $26,498,000 and $1,821,000 in 1999 and 1998 compared to prior years. The decreases were primarily attributable to the sale of the imaging division. MRI revenues as a percentage of total medical services revenues were 0%, 75%, and 76% in years 1999, 1998, and 1997, respectively. The Company's non-MRI diagnostic imaging services revenues decreased $3,345,000 and $1,763,000 in 1999 and 1998 compared to prior years. The decrease in 1999 was due to the sale of the imaging division. The decline in 1998 was primarily due to the continued decline of CT and Nuclear Medicine revenues and the sale of the imaging division. Non-MRI diagnostic imaging services revenues as a percentage of total medical services revenues were 0%, 10% and 14% for the years ended 1999, 1998 and 1997, respectively. Contract service revenues, consisting of Respiratory Therapy services and Cardiac Catheterization Laboratory revenues, decreased $1,150,000 and $195,000 in 1999 and 1998 compared to prior years. These decreases were primarily attributable to the sale of the imaging division. 12 13 COSTS OF OPERATIONS
INCREASE INCREASE 1999 (DECREASE) 1998 (DECREASE) 1997 ------ ---------- ------- ---------- ------- (IN THOUSANDS) Costs of operations..................... $2,165 (91.6)% $25,826 (4.5)% $27,044 Percentage of revenue................... 30.3% 73.5% 72.8%
The Company's costs of operations, consisting of payroll, maintenance and supplies, depreciation and amortization, equipment rental and other operating expenses (such as vehicle fuel, building rents, regional office costs, insurance, property taxes, bad debt expense, fees and training expenses) decreased $23,661,000 in 1999 as compared to 1998 and decreased $1,218,000 in 1998 compared to 1997. Medical services payroll decreased by $7,084,000 in 1999 compared to 1998 and decreased by $446,000 in 1998 compared to 1997. This decrease is primarily due to the sale of the imaging division and the fact that the Company does not currently provide labor as a component of its Gamma Knife services. Medical services payroll costs, as a percent of medical services revenues, were less than 1% in 1999 and remained constant at 20% in years 1998 and 1997. The Company's maintenance and supplies costs were 2%, 15% and 16% of medical service revenues in 1999, 1998 and 1997, respectively. Maintenance and supplies costs decreased $5,041,000 in 1999 compared to 1998 and decreased $775,000 in 1998 vs. 1997. These decreases were primarily due to the sale of the imaging division. Maintenance and supply costs for Gamma Knife services increased $63,000 in 1999 compared to 1998 and decreased $30,000 in 1998 compared to 1997. The increase in 1999 was primarily due to the expiration of the warranty period on three units. The decrease in 1998 compared to 1997 was due to commencement of the warranty period on a replacement Gamma Knife unit at an existing customer. Depreciation and amortization decreased $3,940,000 in 1999 compared to 1998 and decreased $842,000 in 1998 compared to 1997. The decreases in 1999 and 1998 were both primarily attributable to the sale of the imaging division. The decrease in 1999 was partially offset by the addition of four Gamma Knife units during 1999. The decrease in 1998 was also due to fewer MRI units accounted for as capitalized leases in 1998, offset by increases in equipment depreciation due to the addition of two Gamma Knife units during 1998 and one unit in late 1997. Depreciation and amortization for Gamma Knife services in 1999 and in 1998 increased $573,000 and $235,000, respectively, compared to prior years. The increase in 1999 was mitigated because the Company's second Gamma Knife unit, which was sold, was depreciated to its salvage value during third quarter 1999. Equipment rental as a percentage of medical services revenues was 0% in 1999, 12% in 1998 and 7% in 1997. Equipment rental decreased $4,064,000 in 1999 compared to 1998 and increased $1,378,000 in 1998 compared to 1997. The decrease in 1999 was due to the sale of the imaging division. The Company's Gamma Knife services currently do not require the rental of equipment. The increase in 1998 is primarily due to two replacement and three new MRI units accounted for as operating leases during 1998 and fourth quarter 1997, offset by decreases associated with the sale of the imaging division. Other costs of operations as a percentage of medical services revenues were 6%, 11% and 12% in 1999, 1998 and 1997, respectively. The decreases of $3,532,000 in 1999 compared to 1998 and $533,000 in 1998 compared to 1997 were primarily attributable to the sale of the imaging division. Other costs of operations for Gamma Knife services increased $135,000 and $150,000, respectively, compared to prior years. These increases were primarily due to increased insurance costs and property taxes because of additional Gamma Knife units, as well as increased marketing costs. SELLING AND ADMINISTRATIVE
INCREASE INCREASE 1999 (DECREASE) 1998 (DECREASE) 1997 ------ ---------- ------ ---------- ------ (IN THOUSANDS) Selling and administrative costs.......... $1,803 (64.8)% $5,116 (13.3)% $5,901 Percentage of revenue..................... 25.2% 14.6% 15.9%
The Company's selling and administrative costs decreased $3,313,000 in 1999 compared to 1998 and $785,000 in 1998 compared to 1997. The decrease in 1999 was primarily due to the sale of the imaging 13 14 division. Also during 1999, the Company revised its estimate regarding the need for and the corresponding cost of liability insurance related to divested operations. This change in estimate resulted in a $325,000 decrease to selling and administrative expenses during fourth quarter 1999. Selling and administrative costs increased as a percentage of revenue because of the lower revenue base compared to the required level of selling and administrative costs. The decrease in 1998 was primarily due to the sale of the imaging division and decreased salary, investor relations and legal expenses. INTEREST EXPENSE
INCREASE INCREASE 1999 (DECREASE) 1998 (DECREASE) 1997 ------ ---------- ------ ---------- ------ (IN THOUSANDS) Interest expense.......................... $1,309 (58.9)% $3,186 (13.2)% $3,671 Percentage of revenue..................... 18.3% 9.1% 9.9%
The Company's interest expense decreased $1,877,000 in 1999 compared to 1998 and decreased $485,000 in 1998 compared to 1997. The decrease in 1999 was primarily attributable to the sale of the imaging division offset by increased interest related to Gamma Knife units. The decrease in 1998 was primarily attributable to the sale of the imaging division and decreased capitalized lease-related interest, offset by increased interest related to additional Gamma Knife units. Interest expense for Gamma Knife units increased $528,000 in 1999 and $470,000 in 1998 compared to prior years. Interest as a percentage of revenue increased from 9.1% in 1998 to 18.3% in 1999 because all of the Company's operating Gamma Knife units are financed by means of interest bearing debt. OTHER INCOME AND EXPENSE
INCREASE INCREASE 1999 (DECREASE) 1998 (DECREASE) 1997 ----- ---------- ------- ---------- ---- (IN THOUSANDS) (Loss) gain on sale of assets and early termination of capital leases............ $ 10 600.0% $ (2) (100.2)% $821 Percentage of revenue...................... 0.1% 0.0% 2.2% Gain on sale of product line............... $ 0 NM $20,478 NM $ 0 Percentage of revenue...................... 0.0% 58.2% 0.0% Interest and other income.................. $ 603 174.1% $ 220 86.4% $118 Percentage of revenue...................... 8.4% 0.6% 0.3% Minority interest.......................... $(501) 201.8% $ (166) 548.7% $ 37 Percentage of revenue...................... (7.0)% (0.5)% 0.1%
The Company's gain on sale of product line decreased to $0 in 1999 and increased $20,478,000 in 1998 compared to 1997. The gain on sale of product line in 1998 represents the gain associated with the sale of the imaging division. The gain was net of transaction costs of approximately $2,700,000. Transaction costs include legal, investment banking and management bonuses related to the sale of the imaging division; employee severance costs; and the costs related to the discontinuance of the diagnostic imaging division. Gain on sale of assets and early termination of capital leases increased $12,000 in 1999 compared to 1998 and decreased $823,000 in 1998 compared to 1997. The $821,000 gain on sale of assets and early termination of capital leases in 1997 was primarily due to the gain on early termination of a capital lease, an insurance settlement, and gains on sales of assets. Interest and other income increased $383,000 in 1999 and $102,000 in 1998 compared to prior years. The increase in both 1999 and 1998 was primarily due to additional interest income from higher cash balances that are invested in overnight securities. Minority interest increased $335,000 in 1999 and $203,000 in 1998 compared to prior years. Minority interest represents the pre-tax income earned by the minority member's 19% interest in GKF. The increase in minority interest reflects the increased profitability of GKF. 14 15 INCOME TAXES
INCREASE INCREASE 1999 (DECREASE) 1998 (DECREASE) 1997 ---- ---------- ------- ---------- ---- (IN THOUSANDS) Income tax benefit (expense)................ $716 (147.3)% $(1,513) 15,030.0% $(10) Percentage of revenue....................... 10.0% (4.3)% 0.0%
The Company received an income tax benefit of $716,000 in 1999 compared to an income tax provision of $1,513,000 in 1998, a decrease in income tax expense of $2,229,000. The $716,000 income tax benefit is primarily a result of an overestimate of the federal and state income tax provision in 1998 resulting from the sale of the imaging division. The overestimate was adjusted in 1999 when tax returns were completed for filing with taxing agencies. The Company's income tax provision increased $1,503,000 in 1998 compared to 1997 primarily due to the gain on sale of product line. The Company had a net operating loss carryforward for federal income tax return purposes at December 31, 1999 of approximately $8,330,000. NET INCOME
INCREASE INCREASE 1999 (DECREASE) 1998 (DECREASE) 1997 ------ ---------- ------- ---------- ------ (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS) Net income............................... $2,707 (86.5)% $20,051 1,217% $1,522 Net income per share..................... $ 0.68 (83.9)% $ 4.23 1,222% $ 0.32
The Company had net income of $2,707,000 in 1999 compared to net income of $20,051,000 in 1998. Net income for 1999 included an insurance expense credit of $325,000 and a tax benefit of $716,000. Net income for 1998 included a $18,978,000 gain net of income taxes ($1,500,000) primarily from the Sale. Net income for 1998, exclusive of the net gain from the sale of product line was $1,073,000. LIQUIDITY AND CAPITAL RESOURCES The Company had cash and cash equivalents of $12,903,000 at December 31, 1999 compared to $11,114,000 at December 31, 1998. The Company's cash position increased $1,789,000 due primarily to the availability of cash that had previously been classified as restricted until April 15, 1999 to cover potential claims relating to the sale of the imaging division. In addition, during the second quarter 1999 the GK Financing, LLC Operating Agreement was amended to require a minimum cash reserve of $50,000 which resulted in an increase in cash and equivalents of $1,176,000. Restricted cash of $50,000 at December 31, 1999 reflects cash that may only be used for the operations of GK Financing, LLC. At December 31, 1998 restricted cash of $2,226,000 reflected cash that may only be used for GK Financing, LLC and amounts previously described as restricted under terms of the agreements relating to the sale of the imaging division. The Company's total cash, cash equivalents and restricted cash decreased $387,000 in 1999 compared to 1998 due to the payment of federal and state income taxes primarily related to the sale of the imaging division ($1,059,000 net of refunds received), the Company's repurchase of Common Stock and Warrants ($1,164,000) and payment of costs relating to the sale of the imaging division ($1,159,000). Increased cash flow from operations and cash received on the sale of a Gamma Knife unit ($1,200,000) mitigated this decrease. Following the Company's stock repurchases the Company had Shareholders' Equity of $12,639,000, Working Capital of $11,125,000, and Total Assets of $36,986,000 at December 31, 1999 compared to Shareholders' Equity of $11,096,000, Working Capital of $9,088,000, and Total Assets of $26,919,000 as of December 31, 1998. The Company invests its cash in overnight repurchase agreements and commercial paper pending use in the Company's operations. The Company believes its cash position combined with its working capital is adequate to service the Company's cash requirements in 2000. 15 16 IMPACT OF INFLATION AND CHANGING PRICES The Company does not believe that inflation has had a significant impact on operations because a substantial majority of the costs that it incurs under its customer contracts are fixed through the term of the contract. ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA See the Index to Consolidated Financial Statements and Financial Statement Schedules included at page A-1 of this report. ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE On December 31, 1999 the local Grant Thornton offices that provided accounting and tax services for the Company were sold to Moss Adams LLP, an accounting and consulting firm. The Company has elected to retain Moss Adams as its independent auditors and tax advisors. In light of its engagement of Moss Adams, the Company will no longer engage Grant Thornton, LLP to audit the Company's financial statements. Grant Thornton had served as the Company's auditor during the year ended December 31, 1998. Ernst & Young had served as the Company's auditor from 1983 through 1997. The Company on December 14, 1998 engaged Grant Thornton, LLP as its independent accountant to audit the Company's financial statements for the year ended December 31, 1998. The Company and Grant Thornton, LLP had a long established relationship as Grant Thornton had served as the Company's tax advisor since 1990. The Company, during its two prior fiscal years (1998 and 1997) and any subsequent interim period preceding its change of independent accountant, did not have any disagreements with the former accountants on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure. PART III ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT Information regarding directors is incorporated herein by reference from the Company's definitive Proxy Statement for the 2000 Annual Meeting of Shareholders (the "2000 Proxy Statement"). Information regarding executive officers of the Company, included herein under the caption "Executive Officers of the Registrant" in Part I, Item 1 above, is incorporated herein by reference. ITEM 11. EXECUTIVE COMPENSATION Incorporated herein by reference from the 2000 Proxy Statement. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT Incorporated herein by reference from the 2000 Proxy Statement. ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS Incorporated herein by reference from the 2000 Proxy Statement. 16 17 PART IV ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K (A) FINANCIAL STATEMENTS AND SCHEDULES. The following Financial Statements and Schedules are filed with this Report: Report of Independent Auditors Audited Consolidated Financial Statements Consolidated Balance Sheets Consolidated Statements of Income Consolidated Statements of Shareholders' Equity Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements Financial Statement Schedules Valuation and Qualifying Accounts (All other schedules are omitted since the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the financial statements and notes thereto.) (B) EXHIBITS. The following Exhibits are filed with this Report.
EXHIBIT NUMBER: DESCRIPTION: - ------- ------------ 2.1 Securities Purchase Agreement, dated as of March 12, 1998, by and among Alliance Imaging, Inc.; Embarcadero Holding Corp. I; Embarcadero Holding Corp. II; American Shared Hospital Services; and MMRI, Inc.(1) 3.1 Articles of Incorporation of the Company, as amended.(2) 3.2 By-laws of the Company, as amended. 4.6 Form of Common Stock Purchase Warrant of American Shared Hospital Services.(3) 4.8 Registration Rights Agreement, dated as of May 17, 1995, by and among American Shared Hospital Services, the Holders referred to in the Note Purchase Agreement, dated as of May 12, 1995 and General Electric Company, acting through GE Medical Systems.(3) 10.1 The Company's 1984 Stock Option Plan, as amended.(4) 10.2 The Company's 1995 Stock Option Plan, as amended.(5) 10.3 Form of Indemnification Agreement between American Shared Hospital Services and members of its Board of Directors.(4) 10.4 Ernest A. Bates Stock Option Agreement dated as of August 15, 1995.(6) 10.5 Operating Agreement for GK Financing, LLC, dated as of October 17, 1995.(3) 10.6 Amendments dated as of October 26, 1995 and as of December 20, 1995 to the GK Financing, LLC Operating Agreement, dated as of October 17, 1995.(7) 10.7 Amendment dated as of October 16, 1996 to the GK Financing, LLC Operating Agreement, dated as of October 17, 1995.(1) 10.8 Amendment dated as of March 31, 1998 ("Fourth Amendment) to the GK Financing, LLC Operating Agreement dated as of October 17, 1995.(8) 10.9 Amendment dated as of March 31, 1998 ("Fifth Amendment") to the GK Financing, LLC Operating Agreement dated as of October 17, 1995.(8) 10.10 Amendment dated as of June 5, 1998 to the GK Financing, LLC Operating Agreement dated as of October 17, 1995.(8)
17 18
EXHIBIT NUMBER: DESCRIPTION: - ------- ------------ 10.11a Assignment and Assumption Agreement, dated as of December 31, 1995, between American Shared Radiosurgery Services (assignor) and GK Financing, LLC (assignee).(8) 10.11b Assignment and Assumption Agreement, dated as of November 1, 1995, between American Shared Hospital Services (assignor) and American Shared Radiosurgery Services (assignee).(4) 10.11c Amendment Number One dated as of August 1, 1995 to the Lease Agreement for a Gamma Knife Unit between The Regents of the University of California and American Shared Hospital Services. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8) 10.11d Lease Agreement dated as of July 3, 1990 for a Gamma Knife Unit between American Shared Hospital Services and The Regents of the University of California. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8) 10.12 Amendment Number Two dated as of February 6, 1998 to the Lease Agreement for a Gamma Knife Unit between UCSF-Stanford Health Care and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8) 10.13 Assignment and Assumption Agreement, dated as of February 3, 1996, between American Shared Radiosurgery Services (assignor) and GK Financing, LLC (assignee).(4) 10.14 Lease Agreement for a Gamma Knife Unit dated as of April 6, 1994, between Ernest A. Bates, M.D. and NME Hospitals, Inc. dba USC University Hospital. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8) 10.15 Assignment and Assumption and Agreement dated as of February 1, 1996 between Ernest A. Bates, M.D. and GK Financing, LLC with respect to the Lease Agreement for a Gamma Knife dated as of April 6, 1994 between Ernest A. Bates, M.D. and NME Hospitals, Inc. dba USC University Hospital.(8) 10.16 Lease Agreement for a Gamma Knife Unit dated as of October 31, 1996 between Hoag Memorial Hospital Presbyterian and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8) 10.17 Addendum to Lease Agreement for a Gamma Knife Unit dated as of December 1, 1998 between Hoag Memorial Hospital Presbyterian and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8)
18 19
EXHIBIT NUMBER: DESCRIPTION: - ------- ------------ 10.18 Lease Agreement for a Gamma Knife Unit dated as of October 29, 1996 between Methodist Healthcare Systems of San Antonio, Ltd., dba Southwest Texas Methodist Hospital and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8) 10.19 Lease agreement for a Gamma Knife Unit dated as of April 10, 1997 between Yale-New Haven Ambulatory Services Corporation and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8) 10.20 Lease Agreement for a Gamma Knife Unit dated as of June 1, 1998 between GK Financing, LLC and Kettering Medical Center. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9) 10.21 Addendum to Contract with GKF and KMC/WKNI, dated June 1, 1998 between GK Financing, LLC and Kettering Medical Center. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9) 10.22 Lease Agreement for a Gamma Knife Unit dated as of October 5, 1998 between GK Financing, LLC and New England Medical Center Hospitals, Inc. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9) 10.23 Equipment Lease Agreement dated as of October 29, 1998 between GK Financing, LLC and the Board of Trustees of the University of Arkansas on behalf of The University of Arkansas for Medical Sciences. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9) 10.24 First Amendment to Lease Agreement for a Gamma Knife Unit effective as of August 2, 1999 between GK Financing, LLC and TenetHealthSystems Hospitals, Inc. (formerly known as NME Hospitals, Inc.) dba USC University Hospital. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9) 10.25 Addendum Two, dated as of October 1, 1999, to Lease Agreement for a Gamma Knife Unit dated as of October 31, 1996 between Hoag Memorial Hospital Presbyterian and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)
19 20
EXHIBIT NUMBER: DESCRIPTION: - ------- ------------ 10.26 Lease Agreement for a Gamma Knife Unit dated as of May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.) 10.27 Addendum dated June 24, 1999 to Lease Agreement for a Gamma Knife Unit dated as of May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC. 10.28 Amendment dated July 12, 1999 to Lease Agreement for a Gamma Knife Unit dated May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC. 10.29 Amendment dated August 24, 1999 to Lease Agreement for a Gamma Knife Unit dated May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC. 21. Subsidiaries of American Shared Hospital Services. 23.1 Consent of Moss Adams, LLP. 23.2 Consent of Grant Thornton, LLP. 23.3 Consent of Ernst & Young, LLP. 27. Financial Data Schedule for the year ended December 31, 1999.
- --------------- (1) These documents were filed as Exhibits 2.1 and 10.13b, respectively, to the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 1997, which is incorporated herein by this reference. (2) This document was filed as Exhibit 3.1 to registrant's Registration Statement on Form S-2 (Registration No. 33-23416), which is incorporated herein by this reference. (3) These documents were filed as Exhibits 3.2, 4.6 and 4.8, respectively, to registrant's Registration Statement on Form S-1 (Registration No. 33-63721) filed on October 26, 1995, which is incorporated herein by this reference. (4) These documents were filed as Exhibits 10.24 and 10.35 respectively, to registrant's Registration Statement on Form S-2 (Registration No. 33-23416), which is incorporated herein by this reference. (5) This document was filed as Exhibit A to registrant's Proxy Statement, filed on August 31, 1995, which is incorporated herein by this reference. (6) This document was filed as Exhibit B to registrant's Proxy Statement, filed on August 31, 1995, which is incorporated herein by this reference. (7) These documents were filed as Exhibits 4.14 and 10.13, respectively, to the registrant's Pre-Effective Amendment No. 1 to registrant's Registration Statement on Form S-1 (Registration No. 33-63721) filed on March 29, 1996, which is incorporated herein by this reference. (8) These documents were filed as Exhibits 10.8, 10.9, 10.10, 10.11a, 10.11c, 10.11d, 10.12, 10.14, 10.15, 10.16, 10.17, 10.18 and 10.19, respectively, to the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 1998, which is incorporated herein by this reference. (9) These documents were filed as Exhibits 10.20, 10.21, 10.22, 10.23, and 10.24, respectively, to the registrant's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 1999, which is incorporated herein by this reference. (C) REPORTS ON FORM 8-K: None. 20 21 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AMERICAN SHARED HOSPITAL SERVICES (Registrant) March 29, 2000 By: /s/ ERNEST A. BATES ------------------------------------ Ernest A. Bates, M.D. Chairman and Chief Executive Officer Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- /s/ ERNEST A. BATES Chief Executive Officer and March 29, 2000 - -------------------------------------------------------- Chairman of the Board Ernest A. Bates, M.D. /s/ WILLIE R. BARNES Director and Secretary March 29, 2000 - -------------------------------------------------------- Willie R. Barnes /s/ JOHN F. RUFFLE Director March 29, 2000 - -------------------------------------------------------- John F. Ruffle /s/ STANLEY S. TROTMAN, JR. Director March 29, 2000 - -------------------------------------------------------- Stanley S. Trotman, Jr. /s/ CHARLES B. WILSON Director March 29, 2000 - -------------------------------------------------------- Charles B. Wilson /s/ CRAIG K. TAGAWA Chief Operating Officer and March 29, 2000 - -------------------------------------------------------- Chief Financial Officer Craig K. Tagawa (Principal Accounting Officer)
21 22 AMERICAN SHARED HOSPITAL SERVICES CONSOLIDATED FINANCIAL STATEMENTS AND REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS YEARS ENDED DECEMBER 31, 1999, 1998 AND 1997 23 CONTENTS
PAGE ---- REPORTS OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS......... F-2 CONSOLIDATED FINANCIAL STATEMENTS BALANCE SHEETS............................................ F-4 STATEMENTS OF INCOME...................................... F-5 STATEMENT OF SHAREHOLDERS' EQUITY......................... F-6 STATEMENTS OF CASH FLOWS.................................. F-7 NOTES TO FINANCIAL STATEMENTS............................. F-8
F-1 24 REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS The Board of Directors and Shareholders American Shared Hospital Services We have audited the accompanying consolidated balance sheet of American Shared Hospital Services as of December 31, 1999, and the related consolidated statements of income, shareholders' equity, and cash flows for the year then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of American Shared Hospital Services at December 31, 1999, and the consolidated results of their operations and consolidated cash flows for the year then ended in conformity with generally accepted accounting principles. /s/ Moss Adams LLP -------------------------------------- MOSS ADAMS LLP Stockton, California February 18, 2000 F-2 25 REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS The Board of Directors and Shareholders American Shared Hospital Services We have audited the accompanying consolidated balance sheet of American Shared Hospital Services as of December 31, 1998, and the related consolidated statements of operations, shareholders' equity, and cash flows for the year then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of American Shared Hospital Services at December 31, 1998, and the consolidated results of their operations and consolidated cash flows for the year then ended in conformity with generally accepted accounting principles. We have also audited Schedule II for the year ended December 31, 1998. In our opinion, this schedule presents fairly, in all material respects, the information required to be set forth therein. /s/ Grant Thornton LLP -------------------------------------- GRANT THORNTON LLP San Francisco, California March 12, 1999 F-3 26 AMERICAN SHARED HOSPITAL SERVICES CONSOLIDATED BALANCE SHEETS DECEMBER 31, ASSETS
1999 1998 ----------- ----------- CURRENT ASSETS Cash and cash equivalents................................. $12,903,000 $11,114,000 Restricted cash........................................... 50,000 2,226,000 Trade accounts receivable................................. 982,000 1,228,000 Other receivables......................................... 244,000 104,000 Prepaid expenses and other current assets................. 516,000 285,000 ----------- ----------- Total current assets.............................. 14,695,000 14,957,000 PROPERTY AND EQUIPMENT Medical equipment and facilities.......................... 23,560,000 15,199,000 Office equipment.......................................... 617,000 578,000 Deposits and construction in progress..................... 3,276,000 1,079,000 ----------- ----------- 27,453,000 16,856,000 Accumulated depreciation and amortization................. (5,397,000) (5,097,000) ----------- ----------- Net property and equipment........................ 22,056,000 11,759,000 OTHER ASSETS.............................................. 235,000 203,000 ----------- ----------- $36,986,000 $26,919,000 =========== =========== LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable.......................................... $ 101,000 $ 338,000 Accrued interest.......................................... 229,000 54,000 Employee compensation and benefits........................ 87,000 814,000 Other accrued liabilities................................. 597,000 519,000 Income tax payable........................................ -- 1,664,000 Current portion of accrued exit costs..................... 11,000 595,000 Current portion of long-term debt......................... 2,545,000 1,885,000 ----------- ----------- Total current liabilities......................... 3,570,000 5,869,000 LONG-TERM DEBT, less current portion........................ 19,887,000 8,823,000 ACCRUED EXIT COSTS, less current portion.................... -- 400,000 MINORITY INTEREST........................................... 890,000 731,000 SHAREHOLDERS' EQUITY Common stock, $0 par value, authorized -- 10,000,000 shares, issued and outstanding shares -- 3,813,000 in 1999 and 4,544,000 in 1998............................. 10,036,000 11,087,000 Common stock options issued to officer.................... 2,414,000 2,414,000 Additional paid-in capital................................ 817,000 930,000 Accumulated deficit....................................... (628,000) (3,335,000) ----------- ----------- Total shareholders' equity........................ 12,639,000 11,096,000 ----------- ----------- $36,986,000 $26,919,000 =========== ===========
The accompanying notes are an integral part of these statements. F-4 27 AMERICAN SHARED HOSPITAL SERVICES CONSOLIDATED STATEMENTS OF INCOME YEAR ENDED DECEMBER 31,
1999 1998 1997 ---------- ----------- ----------- REVENUES: Medical services................................... $7,156,000 $35,162,000 $37,172,000 COSTS AND EXPENSES: Costs of operations: Medical services payroll........................... 3,000 7,087,000 7,533,000 Maintenance and supplies........................... 143,000 5,184,000 5,959,000 Depreciation....................................... 1,616,000 5,556,000 6,398,000 Equipment rental................................... -- 4,064,000 2,686,000 Other.............................................. 403,000 3,935,000 4,468,000 Selling and administrative......................... 1,803,000 5,116,000 5,901,000 Interest........................................... 1,309,000 3,186,000 3,671,000 ---------- ----------- ----------- Total costs and expenses................... 5,277,000 34,128,000 36,616,000 ---------- ----------- ----------- 1,879,000 1,034,000 556,000 Gain (loss) on sale of assets and early termination of capital leases............................... 10,000 (2,000) 821,000 Gain on sale of product line....................... -- 20,478,000 -- Interest and other income.......................... 603,000 220,000 118,000 Minority interest.................................. (501,000) (166,000) 37,000 ---------- ----------- ----------- Income before income taxes......................... 1,991,000 21,564,000 1,532,000 Income tax benefit (expense)....................... 716,000 (1,513,000) (10,000) ---------- ----------- ----------- Net income......................................... $2,707,000 $20,051,000 $ 1,522,000 ========== =========== =========== Earnings per common share: Earnings per common share -- basic................... $ .68 $ 4.23 $ .32 ========== =========== =========== Earnings per common share -- assuming dilution....... $ .48 $ 3.15 $ .24 ========== =========== ===========
The accompanying notes are an integral part of these statements. F-5 28 AMERICAN SHARED HOSPITAL SERVICES CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY THREE YEARS ENDED DECEMBER 31, 1999
COMMON STOCK OPTIONS ADDITIONAL COMMON COMMON ISSUED TO PAID-IN ACCUMULATED SHARES STOCK OFFICER CAPITAL DEFICIT TOTAL --------- ----------- ---------- ---------- ------------ ------------ Balances at December 31, 1996............ 4,769,000 $11,089,000 $2,414,000 $ 930,000 $(24,908,000) $(10,475,000) Net income....... -- -- -- -- 1,522,000 1,522,000 --------- ----------- ---------- --------- ------------ ------------ Balances at December 31, 1997............ 4,769,000 11,089,000 2,414,000 930,000 (23,386,000) (8,953,000) Repurchase of Common Stock... (225,000) (2,000) -- -- -- (2,000) Net income....... -- -- -- -- 20,051,000 20,051,000 --------- ----------- ---------- --------- ------------ ------------ Balances at December 31, 1998............ 4,544,000 11,087,000 2,414,000 930,000 (3,335,000) 11,096,000 Options exercised... 9,000 16,000 -- -- -- 16,000 Exercise of warrants......... 28,000 21,000 -- -- -- 21,000 Repurchase of common stock............ (768,000) (1,088,000) -- -- -- (1,088,000) Repurchase of warrants......... -- -- -- (113,000) -- (113,000) Net income....... -- -- -- -- 2,707,000 2,707,000 --------- ----------- ---------- --------- ------------ ------------ Balances at December 31, 1999............ 3,813,000 $10,036,000 $2,414,000 $ 817,000 $ (628,000) $ 12,639,000 ========= =========== ========== ========= ============ ============
The accompanying notes are an integral part of these statements. F-6 29 AMERICAN SHARED HOSPITAL SERVICES CONSOLIDATED STATEMENTS OF CASH FLOWS YEAR ENDED DECEMBER 31,
1999 1998 1997 ------------ ------------ ----------- OPERATING ACTIVITIES Net income................................................ $ 2,707,000 $ 20,051,000 $ 1,522,000 Adjustments to reconcile net income to net cash from operating activities: Gain on sale of product line............................ -- (20,478,000) -- (Gain) loss on sale of assets and early termination of capital leases........................................ (10,000) 2,000 (821,000) Depreciation and amortization........................... 1,621,000 6,095,000 6,752,000 Deferred income tax benefit............................. -- (164,000) -- Change in estimate of accrued exit costs................ (375,000) -- -- Changes in operating assets and liabilities: Decrease (increase) in restricted cash................ 2,176,000 (1,575,000) (433,000) Decrease (increase) in receivables.................... 106,000 (154,000) (582,000) (Increase) decrease in prepaid expenses and other assets............................................. (263,000) 187,000 (10,000) (Decrease) increase in accounts payable, accrued liabilities and income taxes payable............... (2,375,000) 3,767,000 843,000 ------------ ------------ ----------- Net cash from operating activities.......................... 3,587,000 7,731,000 7,271,000 INVESTING ACTIVITIES Proceeds from sale of product line, net of selling costs.... -- 12,240,000 -- Payment of accrued exit costs............................... (609,000) -- -- Proceeds from sale and disposition of equipment............. 1,210,000 4,000 331,000 Increase (decrease) in minority interest.................... 159,000 143,000 (37,000) Payment for purchase of property and equipment.............. (131,000) (746,000) (349,000) Other....................................................... -- -- (168,000) ------------ ------------ ----------- Net cash from investing activities.......................... 629,000 11,641,000 (223,000) FINANCING ACTIVITIES Principal payments on long-term debt and obligations under capital leases............................................ (1,513,000) (8,291,000) (8,962,000) Proceeds from issuance of long-term debt.................... 250,000 855,000 -- Payment for exercise of stock warrants...................... 21,000 -- -- Payment for exercise of stock options....................... 16,000 -- -- Net (payments on) proceeds from revolving line of credit.... -- (837,000) 1,563,000 Repurchase of warrants...................................... (113,000) -- -- Repurchase of common stock.................................. (1,088,000) (2,000) -- ------------ ------------ ----------- Net cash from financing activities.......................... (2,427,000) (8,275,000) (7,399,000) ------------ ------------ ----------- Net increase (decrease) in cash and cash equivalents........ 1,789,000 11,097,000 (351,000) Cash and cash equivalents at beginning of year.............. 11,114,000 17,000 368,000 ------------ ------------ ----------- Cash and cash equivalents at end of year.................... $ 12,903,000 $ 11,114,000 $ 17,000 ============ ============ =========== SUPPLEMENTAL CASH FLOW DISCLOSURE Interest paid............................................... $ 1,135,000 $ 3,163,000 $ 3,689,000 ============ ============ =========== Income taxes paid........................................... $ 1,059,000 $ 36,000 $ 29,000 ============ ============ =========== SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES Acquisition of equipment with lease/debt financing.......... $ 13,311,000 $ 6,952,000 $ 3,999,000 Decrease in medical and capitalized lease equipment due to lease restructuring....................................... $ -- $ -- $(1,137,000) Decrease in capitalized lease obligations due to lease restructuring............................................. $ -- $ -- $(2,036,000) Accounts payable converted to notes......................... $ -- $ -- $ 817,000 Net liabilities, primarily trade accounts receivable and payable, property and equipment, capital lease obligations, and long-term debt, assumed by buyer in sale of product line........................................... $ -- $ 9,808,000 $ --
The accompanying notes are an integral part of these statements. F-7 30 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 1999, 1998 AND 1997 NOTE A -- BUSINESS AND BASIS OF PRESENTATION 1. Business American Shared Hospital Services (the "Company") provides Gamma Knife units to eight medical centers in California, Texas, Connecticut, Ohio, Massachusetts, Arkansas, and Wisconsin. The Company provided shared diagnostic imaging services to health care providers located in various geographic regions of the United States through November of 1998. The five diagnostic imaging services provided by the Company were Magnetic Resonance Imaging, Computed Axial Tomography Scanning, Ultrasound, Nuclear Medicine, and Cardiac Catheterization Laboratory services. On November 13, 1998, the diagnostic imaging services product line was sold to a third party. In June 1995, African American Church Health and Economic Services, Inc. (ACHES) and ACHES Insurance Services, Inc. ("AIS") were incorporated. AIS is a wholly owned subsidiary of ACHES. AIS is an insurance agency qualified to sell life, health, and disability insurance in the states of California and New York. ACHES, through AIS, sells life, health and disability insurance primarily to the African-American Community. In 1999, the operations of ACHES and AIS were discontinued. On October 17, 1995, the Company (through American Shared Radiosurgery Services ("ASRS")) and Elekta AB, the manufacturer of the Gamma Knife (through its wholly owned United States subsidiary GKV Investments, Inc. ("GKV")), entered into an operating agreement which formed GK Financing, LLC ("GKF"). GKF provides alternative financing of Elekta Gamma Knife units and is the preferred provider for Elekta AB of financing arrangements, such as fee-for-service lease arrangements with health care institutions. In November, 1999, OR21, Inc., was incorporated. This wholly-owned subsidiary of the Company will provide the product "The Operating Room for the 21st Century(sm)", which is currently under development. The consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, CuraCare, Inc. ("CuraCare"), MMRI, Inc., European Shared Medical Services Ltd., OR21, Inc., ACHES and its wholly-owned subsidiary, AIS, and ASRS and its majority-owned subsidiary, GK Financing, LLC. The stock of CuraCare was sold on November 13, 1998 in conjunction with the sale of the diagnostic imaging services product line. All significant intercompany accounts and transactions have been eliminated in consolidation. NOTE B -- ACCOUNTING POLICIES 1. Use of Estimates in the Preparation of Financial Statements In preparing financial statements in conformity with generally accepted accounting principles, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. 2. Cash and Cash Equivalents The Company considers all liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Restricted cash is not considered a cash equivalent for purposes of the consolidated statements of cash flows. 3. Restricted Cash Restricted cash represents cash limited as to use by contractual arrangement. F-8 31 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 4. Accounts Receivable Substantially all of the Company's revenue is provided by eight customers. These customers constitute accounts receivable at December 31, 1999. The Company performs credit evaluations of its customers and generally does not require collateral. At December 31, 1999, the Company did not maintain an allowance for doubtful accounts because management believes that accounts receivable are fully collectible. 5. Accounting for Majority-Owned Subsidiary The Company accounts for GK Financing, LLC (GKF), as a consolidated entity due to its 81% majority-equity interest. 6. Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets which for medical and office equipment is generally 3 - 10 years. 7. Operating Leases The Company leases Gamma Knife equipment to its customers under arrangements accounted for as operating leases. Revenue is provided for and recognized on a fee-for-service or contingent rental basis when the service is delivered. The lease agreements are generally over ten to fifteen year terms. At December 31, 1999, the Company held equipment under operating lease contracts with customers with an original cost of $22,862,000 and accumulated depreciation of $4,796,000. 8. Income Taxes The liability method is used to account for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. 9. Earnings Per Share In 1997, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 128 ("SFAS 128"), "Earnings per Share." SFAS 128 replaced the calculation of primary and fully diluted earnings per share with basic and diluted earnings per share. Unlike primary earnings per share, basic earnings per share excludes any dilutive effects of options, warrants and convertible securities. Diluted earnings per share is very similar to the previously reported fully diluted earnings per share. All earnings per share amounts for all periods have been presented, and where appropriate, restated to conform to the SFAS 128 requirements. Basic earnings per share has been computed based on the weighted-average number of common shares outstanding. F-9 32 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 The following table sets forth the computation of basic and diluted earnings per share:
1999 1998 1997 ---------- ----------- ---------- Numerator for basic and diluted earnings per share................................... $2,707,000 $20,051,000 $1,522,000 Denominator: Denominator for basic earnings per share -- weighted-average shares.................. 3,967,000 4,735,000 4,769,000 Effect of dilutive securities employee stock options/warrants......................... 1,679,000 1,631,000 1,574,000 ---------- ----------- ---------- Denominator for diluted earnings per share-- adjusted weighted-average shares......... 5,646,000 6,366,000 6,343,000 ========== =========== ========== Earning per share -- basic.................... $ .68 $ 4.23 $ .32 ========== =========== ========== Earning per share -- assuming dilution........ $ .48 $ 3.15 $ .24 ========== =========== ==========
10. Stock-Based Compensation SFAS No. 123, "Accounting for Stock-Based Compensation," encourages but does not require companies to record compensation cost for stock-based employee compensation plans at fair value. The Company has chosen to continue to account for stock-based employee compensation using the intrinsic value method prescribed in Accounting Principles Board (APB) Opinion No. 25, "Accounting for Stock Issued to Employees," and related interpretations. Accordingly, compensation cost for stock options granted to employees is measured as the excess, if any, of the quoted market price of the Company's stock at the date of the grant over the amount an employee must pay to acquire the stock. Disclosure requirements in accordance with SFAS No. 123 are included in Note E. 11. Fair Value of Financial Instruments The carrying amounts of financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and other accrued liabilities approximated their fair value as of December 31, 1999 and 1998, because of the relatively short maturity of these instruments. The carrying amounts of the Company's various debt obligations approximated fair value as of December 31, 1999 and 1998, based upon interest rates that are currently available for the Company for issuance of instruments with similar terms and remaining maturities. 12. Reclassifications Certain amounts in the 1998 financial statements have been reclassified to conform with the 1999 presentation. NOTE C -- LONG-TERM DEBT Long-term debt consists primarily of 8 notes with a financing company, related to Gamma Knife construction and installation, totaling $19,290,000. These notes accrue interest at fixed annual rates between 10.5% and 10.7%, are payable in 84 monthly installments, mature between September, 2004, and November, 2006, and are collateralized by the respective Gamma Knives. Additionally, the Company has $3,142,000 in borrowings outstanding for deposits for two Gamma Knives under construction at December 31, 1999 (note H). These borrowings accrue interest at prime plus 2% (10.5 % at December 31, 1999), are payable when the F-10 33 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 Gamma Knife units commence operation, and are collateralized by the equipment. The following are contractual maturities of long-term debt by year at December 31, 1999: Year ending December 31, 2000........... $ 2,545,000 2001............................... 4,126,000 2002............................... 3,283,000 2003............................... 3,645,000 2004............................... 3,929,000 Thereafter......................... 4,904,000 ----------- $22,432,000 ===========
NOTE D -- INCOME TAXES Significant components of the Company's deferred tax liabilities and assets as of December 31, 1999 and 1998 are as follows:
1999 1998 ----------- ----------- Deferred tax liabilities: Fixed assets......................................... $(2,389,000) $(1,000,000) ----------- ----------- Total deferred tax liabilities.................. (2,389,000) (1,000,000) Deferred tax assets: Net operating loss carryforwards..................... 2,941,000 275,000 State income taxes................................... -- 450,000 Accrued reserves..................................... 5,000 710,000 Other -- net......................................... 300,000 360,000 ----------- ----------- Total deferred tax assets....................... 3,246,000 1,795,000 Valuation allowance for deferred tax assets............. (857,000) (795,000) ----------- ----------- Net deferred tax assets................................. 2,389,000 1,000,000 ----------- ----------- Net deferred tax liabilities............................ $ -- $ -- =========== ===========
The components of the provision (benefit) for income taxes consist of the following:
1999 1998 1997 --------- ---------- ------- Current: Federal.......................................... $ -- $ 360,000 $ -- State............................................ (716,000) 1,317,000 10,000 --------- ---------- ------- Deferred: Federal.......................................... -- -- -- State............................................ -- (164,000) -- --------- ---------- ------- $(716,000) $1,513,000 $10,000 ========= ========== =======
F-11 34 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 The provision (benefit) for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (34% in 1999, 1998 and 1997) to income (loss) before taxes as follows:
1999 1998 1997 ----------- ----------- ----------- Computed expected tax..................... $ 677,000 $ 7,500,000 $ 536,000 Change in valuation allowance........... 62,000 (7,205,000) (1,600,000) State income taxes, net of federal benefit.............................. 116,000 1,400,000 10,000 Change in carryovers and tax attributes........................... (1,571,000) -- 984,000 Other................................... -- (182,000) 80,000 ----------- ----------- ----------- $ (716,000) $ 1,513,000 $ 10,000 =========== =========== ===========
At December 31, 1999, the Company had a net operating loss carryforward for federal income tax return purposes of approximately $8,330,000 which expires between 1999 and 2019. A substantial part of this carryforward is subject to separate return limitations. The Company's ability to utilize its net operating loss carryforwards and other deferred tax assets may be limited in the event of a 50% or more ownership change within any three-year period. The Company's estimated income tax liability for the year ended December 31, 1998 was overstated by approximately $700,000. This change in estimate is the result of finalization of unresolved details associated with the 1998 sale of the diagnostic imaging services product line. The effect of the resolution of these details was estimated in the 1998 financial statements. The effect of the final resolution was a reduction of the Company's income tax liability resulting in an income tax benefit for the year ended December 31, 1999 as well as an increase in the net operating loss carryforwards available to the Company. The tax effected amount of the increase in net operating losses is approximately $1,571,000 and is reflected as a change in carryovers and tax attributes in the reconciliation from expected to actual income tax expense above. NOTE E -- SHAREHOLDERS' EQUITY 1984 Stock Option Plan Under the Company's 1984 Stock Option Plan (the "Plan"), as amended, a total of 475,000 stock options were authorized for grant. The Plan terminated according to its terms on March 1, 1994. Options granted pursuant to the Plan generally had lives of 10 years from the date of grant, subject to earlier expiration in certain cases, such as termination of the grantee's employment. 1995 Stock Option Plan The Company's 1995 Stock Option Plan, providing for nonqualified stock options and "incentive stock options," was approved by the Company's Board of Directors on August 15, 1995, subject to shareholder approval, which was given on October 6, 1995. Under the 1995 Plan, 330,000 common shares are reserved for awards to officers and other key employees, non-employee directors, and advisors. Provisions of the 1995 Stock Option Plan include an automatic grant to each non-employee director of options to purchase up to 4,000 shares annually on the date of the Company's Annual Shareholder Meeting, at an exercise price equal to the market price of the Company's common shares on that date, until the non-employee director has options for a total of 12,000 shares of the Company's common stock in all Company plans. Directors who are appointed or elected to the Company's Board of Directors on a date other than that of the Annual Shareholder Meeting receive a pro-rata grant of such options, at an exercise price equal to the market price of the Company's common shares on the date of grant. F-12 35 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 Changes in options outstanding under the 1984 and 1995 Stock Option Plans from January 1, 1997 to December 31, 1999 are as follows:
WEIGHTED AVERAGE NUMBER EXERCISE OF OPTIONS PRICE ---------- -------- Balance at January 1, 1997.................................. 417,000 $1.625 Granted................................................... 14,000 $1.688 Exercised................................................. -- -- Forfeited................................................. (2,000) $1.596 ------- ------ Balance at December 31, 1997................................ 429,000 $1.627 Granted................................................... -- $ -- Exercised................................................. -- $ -- Forfeited................................................. (40,000) $1.625 ------- ------ Balance at December 31, 1998................................ 389,000 $1.628 Granted................................................... 53,000 $3.000 Exercised................................................. (9,000) $1.660 Forfeited................................................. (58,000) $1.625 ------- ------ Balance at December 31, 1999................................ 375,000 $1.820 ======= ======
At December 31, 1999, 43,000 options were available for grant under the 1995 Plan. Shares and Options Issued to Officer On August 15, 1995, the Company's Chairman and Chief Executive Officer was granted a ten-year, immediately exercisable option to purchase 1,495,000 common shares for an exercise price of $.01 per share for which the Company recorded compensation expense of $2,414,000. These options were granted to the officer as final consideration for personal guarantees of credit facilities and for continued employment with the Company. The following table summarizes information about all options outstanding at December 31, 1999:
OPTIONS OUTSTANDING OPTIONS EXERCISABLE ------------------------------------- ---------------------- WEIGHTED AVERAGE WEIGHTED WEIGHTED REMAINING AVERAGE AVERAGE RANGE OF NUMBER CONTRACTUAL EXERCISE NUMBER EXERCISE EXERCISE PRICES OUTSTANDING LIFE (YEARS) PRICE EXERCISABLE PRICE - --------------- ----------- ------------ -------- ----------- -------- $0.01 1,495,000 5.83 $ 0.01 1,495,000 $ 0.01 1.625 - 3.000 375,000 5.37 1.820 361,000 1.772 --------- ---- ------ --------- ------ $ .01 - 3.000 1,870,000 5.74 $ .373 1,856,000 $ .352 ========= ==== ====== ========= ======
At December 31, 1999 and 1998, 1,856,000 and 1,884,000 options, respectively, were vested and exercisable. At December 31, 1999, there were 1,370 warrants outstanding at an exercise price of $.75 per warrant. These warrants are exercisable through May 2002. Pro Forma Information related to Option Grants Pro forma information regarding net income and earnings per share is required by SFAS 123 for awards granted after December 31, 1995, as if the Company had accounted for its stock-based awards to employees under the fair value method of SFAS 123. The fair value of the Company's stock-based awards to employees was estimated using a Black-Scholes option pricing model. The Black-Scholes options valuation model was F-13 36 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, the Black-Scholes model requires the input of highly subjective assumptions including the expected stock price volatility. Because the Company's stock-based awards to employees have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its stock-based awards to employees. The fair value of the Company's option grants under the 1984 and 1995 Plans was estimated assuming no expected dividends and the following weighted-average assumptions:
1999 1998 1997 ---- ---- ---- Expected life (years)....................................... 9.5 9.5 9.5 Expected volatility......................................... 82.0% 93.8% 93.8% Risk-free interest rate..................................... 5.9% 6.3% 6.3%
No options were granted during 1998. The weighted-average fair value of options granted during 1999 was $2.54. For pro forma purposes, the estimated fair value of the Company's options is amortized over the options' vesting period. The Company's pro forma information follows:
1999 1998 1997 ---------- ----------- ---------- Net income As reported................................. $2,707,000 $20,051,000 $1,522,000 Pro forma................................... $2,595,000 $20,040,000 $1,458,000 Earnings per share -- basic As reported................................. $ .68 $ 4.23 $ .32 Pro forma................................... $ .65 $ 4.23 $ .31 Earnings per share -- assuming dilution As reported................................. $ .48 $ 3.15 $ .24 Pro forma................................... $ .46 $ 3.15 $ .23
NOTE F -- RETIREMENT PLAN The Company has a defined contribution retirement plan for which substantially all full-time employees are eligible. The plan does not currently provide for a Company matching distribution. NOTE G -- OPERATING LEASES The Company leases office space and equipment under operating leases expiring at various dates through 2002. Future minimum payments under noncancelable operating leases having initial terms of more than one year consisted of the following at December 31, 1999: 2000.............................................. $153,000 2001.............................................. 137,000 2002.............................................. 101,000 -------- $391,000 ========
Payments for repair and maintenance agreements are included in the future minimum operating lease payments shown above. Rent expense was $117,000, $4,696,000, and $3,285,000 for the years ended December 31, 1999, 1998 and 1997, respectively, and includes the above operating leases as well as month-to-month rental and certain capital lease executory costs. F-14 37 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 NOTE H -- COMMITMENTS AND CONTINGENCIES Under the terms of 2 Gamma Knife quotation agreements, the Company is committed to purchase Gamma Knife equipment for $6,136,000 effective when the equipment is placed in service at each customer location. At December 31, 1999, the Company had $3,142,000 in deposits related to these purchase commitments which are classified as construction in progress. NOTE I -- REPORTABLE SEGMENTS American Shared Hospital Services (ASHS) has one reportable segment: Gamma Knife. The Gamma Knife segment treats certain vascular malformations and intracranial tumors without surgery. Prior to November 1998 the Company also had a Diagnostic Imaging Services segment which used medical diagnostic imaging systems to facilitate treatment and the diagnosis of diseases and disorders. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. ASHS evaluates performance based on profit or loss from operations before income taxes not including nonrecurring gains and losses. Applicable general and administrative expenses are allocated to segments based on relative percentage of revenues. Certain corporate expenses are not allocated to the segments. ASHS does not have significant intersegment sales transactions. The segments share common expenses and provide management activities to one another for which they charge management fees. These management fees are not considered significant. ASHS's reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different technology and marketing strategies. Reportable Segment Information
DIAGNOSTIC IMAGING SERVICES ----------------------------- 1999 1998 1997 ----- -------- -------- (THOUSANDS) Revenues................................................. $-- $30,993 $34,772 Interest expense......................................... $-- $ 1,770 $ 2,571 Depreciation and amortization............................ $-- $ 4,514 $ 5,590 Segment profit........................................... $-- $ 156 $ 1,208 Segment assets........................................... $-- $ -- $20,905 Other significant noncash items: Acquisition of equipment with lease/debt financing..... $-- $ 820 $ 1,767 Capitalized lease restructuring........................ $-- $ -- $(3,173) Accounts payable converted to notes payable............ $-- $ -- $ 817
GAMMA KNIFE ---------------------------- 1999 1998 1997 ------- ------- ------ (THOUSANDS) Revenues............................................... $ 7,151 $ 4,156 $2,384 Interest expense....................................... $ 1,305 $ 773 $ 303 Depreciation and amortization.......................... $ 2,135 $ 1,042 $ 808 Segment profit......................................... $ 2,637 $ 1,115 $ 392 Segment assets......................................... $28,920 $15,125 $7,859 Other significant noncash items: Acquisition of equipment with lease/debt financing... $13,311 $ 6,132 $2,232
F-15 38 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 Reconciliation to Consolidated Amounts
1999 1998 1997 ------- ------- ------- (THOUSANDS) REVENUES Total revenues for reportable segments................ $ 7,151 $35,149 $37,156 Other revenues........................................ 5 13 16 ------- ------- ------- Total consolidated revenues...................... 7,156 35,162 37,172 PROFIT OR LOSS Total profit for reportable segments.................. 2,637 1,271 1,600 Gain on sale of product line.......................... -- 20,478 -- Other................................................. (646) (185) (68) ------- ------- ------- Income before income taxes....................... 1,991 21,564 $ 1,532 ASSETS Total assets for reportable segments.................. 28,920 15,025 28,764 Other assets.......................................... 8,066 12,042 1,907 Elimination of receivables from corporate headquarters........................................ -- (148) (462) ------- ------- ------- Consolidated total.......................... $36,986 $26,919 $30,209 ======= ======= =======
Other Significant Items
1999 ------------------------------------ SEGMENT CONSOLIDATED TOTALS ADJUSTMENTS TOTALS ------- ----------- ------------ (THOUSANDS) Interest expense...................................... $1,305 $ 4 $1,309 Expenditures for assets............................... $ -- $ 131 $ 131 Depreciation and amortization......................... $2,135 $(514) $1,621
1998 ------------------------------------ SEGMENT CONSOLIDATED TOTALS ADJUSTMENTS TOTALS ------- ----------- ------------ Interest expense...................................... $2,543 $ 643 $3,186 Expenditures for assets............................... $ 50 $ 5 $ 55 Depreciation and amortization......................... $5,556 $ -- $5,556
1997 ------------------------------------ SEGMENT CONSOLIDATED TOTALS ADJUSTMENTS TOTALS ------- ----------- ------------ Interest expense...................................... $2,874 $ 797 $3,671 Expenditures for assets............................... $ 320 $ 26 $ 346 Depreciation and amortization......................... $6,398 $ -- $6,398
Adjustments to reconcile reportable segment totals to consolidated totals include unallocated amounts and amounts from non-reportable segments. Major Customers Revenues from the Company's Gamma Knife segment were provided by eight customers in 1999, five customers in 1998, and three customers in 1997. F-16 39 AMERICAN SHARED HOSPITAL SERVICES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999, 1998 AND 1997 NOTE J -- SALE OF PRODUCT LINE On November 13, 1998, the Company consummated a sale of its diagnostic imaging services product line to a third party. The diagnostic imaging services line included Magnetic Resonance Imaging (MRI), Computed Axial Tomography Scanning (CT), Ultrasound, Nuclear Medicine and Cardiac Catheterization Laboratory services. The Company sold the assets of this product line for $13.5 million in cash and the assumption by the third party of approximately $27.1 million in liabilities of the Company. The Company recognized a gain on disposal of product line of approximately $20 million in conjunction with this transaction. In conjunction with the product line sale, one of the Company's facilities which provided certain administrative and scheduling functions was closed during 1999. At December 31, 1998, in accordance with the Emerging Issues Task Force (EITF) Abstract 94-3, the Company accrued certain future exit costs related to the sale of the product line and corresponding facility closure which totaled $995,000 at December 31, 1998. The accrued costs include employee compensation of $215,000, liability tail insurance coverage costs of $500,000, legal and professional fees of $105,000, administrative costs of $115,000 and other costs totaling $60,000. Insurance costs of approximately $400,000 were classified as long-term as they were intended to be incurred subsequent to 1999. During 1999, management revised its estimate regarding the use and corresponding cost of liability tail insurance coverage. This change in estimate resulted in a $325,000 decrease to selling and administrative expenses in the corresponding Statement of Income for the year ended December 31, 1999. The revenue and net operating income or losses from the disposed diagnostic imaging services line for fiscal years ended 1998 and 1997 are presented at Note I. F-17 40 AMERICAN SHARED HOSPITAL SERVICES SCHEDULE II -- VALUATION AND QUALIFYING ACCOUNTS DECEMBER 31, 1999, 1998 AND 1997
BALANCE AT ADDITIONS BALANCE AT ADDITIONS JANUARY 1, CHARGED TO AMOUNTS DECEMBER 31, CHARGED TO AMOUNTS 1997 COSTS AND EXPENSES WRITTEN OFF 1997 COST EXPENSES WRITTEN OFF ----------- ------------------ ----------- ------------ ------------- ----------- Allowance for uncollectible accounts............... $(1,240,000) $(1,296,000) $1,234,000 $(1,302,000) $(1,095,000) $1,031,000 ASSUMED BY BALANCE AT BUYER IN DECEMBER 31, PRODUCT LINE SALE 1998 ----------------- ------------ Allowance for uncollectible accounts............... $1,366,000 $--
F-18 41 INDEX TO EXHIBITS
EXHIBIT SEQUENTIAL NUMBER DESCRIPTION PAGE NUMBER ------- ----------- ----------- 2.1 Securities Purchase Agreement, dated as of March 12, 1998, * by and among Alliance Imaging, Inc.; Embarcadero Holding Corp. I; Embarcadero Holding Corp. II; American Shared Hospital Services; and MMRI, Inc.(1)........................ 3.1 Articles of Incorporation of the Company, as amended.(2) * 3.2 By-laws of the Company, as amended.......................... 4.6 Form of Common Stock Purchase Warrant of American Shared * Hospital Services.(3)....................................... 4.8 Registration Rights Agreement, dated as of May 17, 1995, by * and among American Shared Hospital Services, the Holders referred to in the Note Purchase Agreement, dated as of May 12, 1995 and General Electric Company, acting through GE Medical Systems.(3)......................................... 10.1 The Company's 1984 Stock Option Plan, as amended.(4)........ * 10.2 The Company's 1995 Stock Option Plan, as amended.(5)........ * 10.3 Form of Indemnification Agreement between American Shared * Hospital Services and members of its Board of Directors.(4)............................................... 10.4 Ernest A. Bates Stock Option Agreement dated as of August * 15, 1995.(6)................................................ 10.5 Operating Agreement for GK Financing, LLC, dated as of * October 17, 1995.(3).................................................... 10.6 Amendments dated as of October 26, 1995 and as of December * 20, 1995 to the GK Financing, LLC Operating Agreement, dated as of October 17, 1995.(7).................................................... 10.7 Amendment dated as of October 16, 1996 to the GK Financing, * LLC Operating Agreement, dated as of October 17, 1995.(1)... 10.8 Amendment dated as of March 31, 1998 ("Fourth Amendment") to * the GK Financing, LLC Operating Agreement dated as of October 17, 1995.(8)........................................ 10.9 Amendment dated as of March 31, 1998 ("Fifth Amendment") to * the GK Financing, LLC Operating Agreement dated as of October 17, 1995.(8)........................................ 10.10 Amendment dated as of June 5, 1998 to the GK Financing, LLC * Operating Agreement dated as of October 17, 1995.(8)........ 10.11a Assignment and Assumption Agreement, dated as of December * 31, 1995, between American Shared Radiosurgery Services (assignor) and GK Financing, LLC (assignee).(8)............. 10.11b Assignment and Assumption Agreement, dated as of November 1, * 1995, between American Shared Hospital Services (assignor) and American Shared Radiosurgery Services (assignee).(4).... 10.11c Amendment Number One dated as of August 1, 1995 to the Lease * Agreement for a Gamma Knife Unit between The Regents of the University of California and American Shared Hospital Services. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8).............................................. 10.11d Lease Agreement dated as of July 3, 1990 for a Gamma Knife * Unit between American Shared Hospital Services and The Regents of the University of California. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8)...........
42
EXHIBIT SEQUENTIAL NUMBER DESCRIPTION PAGE NUMBER ------- ----------- ----------- 10.12 Amendment Number Two dated as of February 6, 1998 to the * Lease Agreement for a Gamma Knife Unit between UCSF-Stanford Health Care and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8)....................... 10.13 Assignment and Assumption Agreement, dated as of February 3, * 1996, between American Shared Radiosurgery Services (assignor) and GK Financing, LLC (assignee).(4)............. 10.14 Lease Agreement for a Gamma Knife Unit dated as of April 6, * 1994, between Ernest A. Bates, M.D. and NME Hospitals, Inc. dba USC University Hospital. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8)....................... 10.15 Assignment and Assumption Agreement dated as of February 1, * 1996 between Ernest A. Bates, M.D. and GK Financing, LLC with respect to the Lease Agreement for a Gamma Knife dated as of April 6, 1994 between Ernest A. Bates, M.D. and NME Hospitals, Inc. dba USC University Hospital.(8)............. 10.16 Lease Agreement for a Gamma Knife Unit dated as of October * 31, 1996 between Hoag Memorial Hospital Presbyterian and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8).............................................. 10.17 Addendum to Lease Agreement for a Gamma Knife Unit dated as * of December 1, 1998 between Hoag Memorial Hospital Presbyterian and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8)....................... 10.18 Lease Agreement for a Gamma Knife Unit dated as of October * 29, 1996 between Methodist Healthcare Systems of San Antonio, Ltd., dba Southwest Texas Methodist Hospital and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8).............................................. 10.19 Lease Agreement for a Gamma Knife Unit dated as of April 10, * 1997 between Yale-New Haven Ambulatory Services Corporation and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(8).............................................. 10.20 Lease Agreement for a Gamma Knife Unit dated as of June 1, * 1998 between GK Financing, LLC and Kettering Medical Center. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9)..............................................
43
EXHIBIT SEQUENTIAL NUMBER DESCRIPTION PAGE NUMBER ------- ----------- ----------- 10.21 Addendum to Contract with GKF and KMC/WKNI, dated June 1, * 1998 between GK Financing, LLC and Kettering Medical Center. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9).............................................. 10.22 Lease Agreement for a Gamma Knife Unit dated as of October * 5, 1998 between GK Financing, LLC and New England Medical Center Hospitals, Inc. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9).............................................. 10.23 Equipment Lease Agreement dated as of October 29, 1998 * between GK Financing, LLC and the Board of Trustees of the University of Arkansas on behalf of The University of Arkansas for Medical Sciences. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9)....................... 10.24 First Amendment to Lease Agreement for a Gamma Knife Unit * effective as of August 2, 1999 between GK Financing, LLC and Tenet HealthSystems Hospitals, Inc. (formerly known as NME Hospitals, Inc.) dba USC University Hospital. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)(9)........... 10.25 Addendum Two, dated as of October 1, 1999, to Lease Agreement for a Gamma Knife Unit dated as of October 31, 1996 between Hoag Memorial Hospital Presbyterian and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)................................................. 10.26 Lease Agreement for a Gamma Knife Unit dated as of May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)................................................. 10.27 Addendum dated June 24, 1999 to Lease Agreement for a Gamma Knife Unit dated as of May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC............ 10.28 Addendum dated July 12, 1999 to Lease Agreement for a Gamma Knife Unit dated as of May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC. 10.29 Addendum dated August 24, 1999 to Lease Agreement for a Gamma Knife Unit dated as of May 28, 1999 between Froedtert Memorial Lutheran Hospital and GK Financing, LLC............
44
EXHIBIT SEQUENTIAL NUMBER DESCRIPTION PAGE NUMBER ------- ----------- ----------- 21. Subsidiaries of American Shared Hospital Services........... 23.1 Consent of Moss Adams, LLP.................................. 23.2 Consent of Grant Thornton, LLP.............................. 23.3 Consent of Ernst & Young, LLP............................... 27. Financial Data Schedule for the year ended December 31, 1999........................................................
- --------------- (1) These documents were filed as Exhibits 2.1 and 10.13b, respectively, to the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 1997, which is incorporated herein by this reference. (2) This document was filed as Exhibit 3.1 to registrant's Registration Statement on Form S-2 (Registration No. 33-23416), which is incorporated herein by this reference. (3) These documents were filed as Exhibits 3.2, 4.6 and 4.8, respectively, to registrant's Registration Statement on Form S-1 (Registration No. 33-63721) filed on October 26, 1995, which is incorporated herein by this reference. (4) These documents were filed as Exhibits 10.24 and 10.35 respectively, to registrant's Registration Statement on Form S-2 (Registration No. 33-23416), which is incorporated herein by this reference. (5) This document was filed as Exhibit A to registrant's Proxy Statement, filed on August 31, 1995, which is incorporated herein by this reference. (6) This document was filed as Exhibit B to registrant's Proxy Statement, filed on August 31, 1995, which is incorporated herein by this reference. (7) These documents were filed as Exhibits 4.14 and 10.13, respectively, to the registrant's Pre-Effective Amendment No. 1 to registrant's Registration Statement on Form S-1 (Registration No. 33-63721) filed on March 29, 1996, which is incorporated herein by this reference. (8) These documents were filed as Exhibits 10.8, 10.9, 10.10, 10.11a, 10.11c, 10.11d, 10.12, 10.14, 10.15, 10.16, 10.17, 10.18 and 10.19, respectively, to the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 1998, which is incorporated herein by this reference. (9) These documents were filed as Exhibits 10.20, 10.21, 10.22, 10.23, and 10.24, respectively, to the registrant's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 1999, which is incorporated herein by this reference. EX-3.2 2 BYLAWS 1 Exhibit 3.2 BYLAWS OF AMERICAN SHARED HOSPITAL SERVICES (a California corporation) Amended and Restated as of May 21, 1999 1 2 TABLE OF CONTENTS
Page ARTICLE I - Applicability 1 Section 1. Applicability of By-laws. 1 ARTICLE II - Offices Section 1. Principal Offices. 1 Section 2. Change in Location or Number of Offices. 1 ARTICLE III - Meetings of Shareholders 1 Section 1. Place of Meetings. 1 Section 2. Annual Meetings. 1 Section 3. Special Meetings. 3 Section 4. Notice of Annual, Special or Adjourned 3 Meetings. Section 5. Record Date. 6 Section 6. Quorum. 7 Section 7. Adjournment. 7 Section 8. Validation of Action Taken at Defectively 7 Called, Noticed or Held Meetings. Section 9. Voting for Election of Directors. 7 Section 10. Proxies. 8 Section 11. Inspectors of Election. 9 Section 12. Action by Written Consent. 9 ARTICLE IV - Directors 10 Section 1. Number of Directors. 10 Section 2. Election of Directors. 11
2 3 Section 3. Term of Office. 11 Section 4. Vacancies. 11 Section 5. Removal. 12 Section 6. Resignation. 12 Section 7. Fees and Compensation. 12 ARTICLE V - Committees of the Board of Directors. 13 Section 1. Designation of Committees. 13 Section 2. Powers of Committees. 13 ARTICLE VI - Meetings of the Board of Directors and 13 Committees Thereof. Section 1. Place of Meetings. 13 Section 2. Organization Meeting. 14 Section 3. Other Regular Meetings. 14 Section 4. Special Meetings. 14 Section 5. Notice of Special Meetings. 14 Section 6. Waivers, Consents and Approvals. 14 Section 7. Quorum; Action at Meetings; Telephone 15 Meetings Section 8. Adjournment. 15 Section 9. Action Without a Meeting. 15 Section 10. Meetings of and Action by Committees. 15 ARTICLE VII - Officers 15 Section 1. Officers. 15 Section 2. Election of Officers. 16
3 4 Section 3. Subordinate Officers, Etc. 16 Section 4. Removal and Resignation. 16 Section 5. Vacancies. 16 Section 6. Chairman of the Board. 16 Section 7. President. 17 Section 8. Vice President. 17 Section 9. Secretary. 17 Section 10. Chief Financial Officer. 17 ARTICLE VIII - Records and Reports 18 Section 1. Minute Book. 18 Section 2. Share Register. 18 Section 3. Books and Records of Account. 18 Section 4. By-laws. 18 Section 5. Inspection of Records. 19 Section 6. Annual Report to Shareholders. 19 ARTICLE IX - Miscellaneous 19 Section 1. Checks, Drafts, Etc. 19 Section 2. Contracts, Etc. - How Executed. 19 Section 3. Certificates of Stock. 19 Section 4. Lost Certificates. 20 Section 5. Representation of Shares of Other 20 Corporations. Section 6. Construction and Definitions. 20 Section 7. Mandatory Indemnification of Directors 20
4 5 Section 8. Permissive Indemnification. 21 Section 9. Payment of Expenses in Advance. 21 Section 10. Indemnity Not Exclusive. 21 Section 11. Insurance Indemnification. 22 Section 12. Conflicts. 22 ARTICLE X - Amendments 22 Section 1. Amendments. 22
5 6 BYLAWS OF AMERICAN SHARED HOSPITAL SERVICES (a California corporation) ARTICLE I Applicability Section 1. Applicability of By-laws. These By-laws govern, except as otherwise provided by statute or its Articles of Incorporation, the management of the business and the conduct of the affairs of the Corporation. ARTICLE II Offices Section 1. Principal Offices. The Board of Directors shall fix the location of the principal executive office of the Corporation at any place within or outside the State of California. If the principal executive office is located outside this state, and the Corporation has one or more business offices in this state, the Board of Directors shall designate a principal business office in the State of California. Section 2. Change in Location or Number of Offices. The Board of Directors may change any office from one location to another or eliminate any office or offices. ARTICLE III Meetings of Shareholders Section 1. Place of Meetings. Meetings of the shareholders shall be held at any place within or without the State of California designated by the Board of Directors, or, in the absence of such designation, at the principal executive office of the Corporation. Section 2. Annual Meetings. (a) An annual meeting of the shareholders shall be held within 180 days following the end of the fiscal year of the Corporation at a date and time designated by the Board of Directors. Directors shall be elected at each 6 7 annual meeting and any other proper business may be transacted thereat. (b) Only persons who are nominated in accordance with the procedures set forth in this paragraph (b) shall be eligible for election as directors of the Corporation. Nominations of persons for election to the Board of Directors may be made at a meeting of shareholders by the Board of Directors or by any stockholder of the Corporation entitled to vote in the election of directors at the meeting who complies with the notice procedures set forth in this paragraph (b). Any nomination by a stockholder must be made by written notice to the Secretary delivered or mailed to and received at the principal executive offices of the Corporation (i) not less than 60 days nor more than 90 days prior to the meeting, or (ii) if less than 70 days' notice of the meeting or prior public disclosure of the date of the meeting is given or made to shareholders, not later than the close of business on the tenth day following the day on which the notice of the meeting was mailed, or, if earlier, the day on which such public disclosure was made. A shareholders' notice to the Secretary shall set forth (x) as to each person whom the stockholder proposes to nominate for election or re-election as a director: (a) the name, age, business address and residence address of such person, (2) the principal occupation or employment of such person, (3) the class and number of shares of stock of the Corporation which are beneficially owned by such person (for the purposes of the regulations under Sections 13 and 14 of the Securities Exchange Act of 1934, as amended), and (4) any other information relating to such person that would be required to be disclosed in solicitations of proxies for the election of such person as a director of the Corporation pursuant to Regulation 14A under the Securities and Exchange Act of 1934, as amended, and such person's written consent to being named in any proxy statement as a nominee and to serving as a director if elected; and (y) as to the stockholder giving notice (5) the name and address, as they appear on the Corporation's records, of such stockholder and (6) the class and number of shares of stock of the Corporation which are beneficially owned by such stockholder (determined as provided in clause (x) (3) above). At the request of the Board of Directors any person nominated by the Board of Directors for election as a director shall furnish to the Secretary that information required to be set forth in a stockholder's notice of nomination which pertains to the nominee. The chairman of the meeting at which a stockholder nomination is presented shall, if the facts warrant, determine and declare to the meeting that such nomination was not made in accordance with the procedures prescribed by this 7 8 paragraph (b), and, in such event, the defective nomination shall be disregarded. Section 3. Special Meetings. (a) Special meetings of the shareholders may be called by the Board of Directors, the Chairman of the Board and the President, or by the shareholders upon the request of the holders of shares entitled to cast not less than 10 percent of the votes at such meeting. (b) Any request for the calling of a special meeting of the shareholders shall (1) be in writing, (2) specify the date and time thereof, which date shall be not less than 35 nor more than 60 days after receipt of the request, (3) specify the general nature of the business to be transacted thereat in accordance with Section 4(f) below and (4) be given either personally or by first class mail, postage prepaid, or other means of written communication to the Chairman of the Board, President, any Vice President or Secretary of the Corporation. The officer receiving a proper request to call a special meeting of the shareholders shall cause notice to be given, pursuant to the provisions of Section 4 of this article, to the shareholders entitled to vote thereat, that a meeting will be held at the date and time specified by the person or persons calling the meeting. If notice is not given within 20 days of the receipt of the request, the shareholders making the request may give notice of such meeting so long as the notice given complies with the other provisions of this subsection. (c) No business may be transacted at a special meeting unless the general nature thereof was stated in the notice of such meeting. Section 4. Notice of Annual, Special or Adjourned Meetings. (a) Whenever any meeting of the shareholders is to be held, a written notice of such meeting shall be given in the manner described in subdivision (d) of this section not less than 10 nor more than 60 days before the date thereof, to each shareholder entitled to vote thereat. The notice shall state the place, date and hour of the meeting and (1) in the case of a special meeting, the general nature of the business to be transacted or (2) in the case of the annual meeting, those matters which the Board of Directors, at the time of the giving of the notice, intends to present for action by the shareholders, in each case in accordance with Section 4(f) below. The notice of any meeting at which directors are to be elected shall include the name of any nominee or nominees who, 8 9 at the time of the notice, management intends to present for election. (b) Any proper matter may be presented at an annual meeting for action. However, any action to approve (1) a contract or transaction in which a director has a direct or indirect financial interest under Section 310 of the Corporations Code of California, (2) an amendment of the articles of incorporation under Section 902 of that code, (3) a reorganization of the corporation, under Section 1201 of that code, (4) a voluntary dissolution of the corporation under Section 1900 of that code, or (5) a distribution in dissolution other than in accordance with the rights of outstanding preferred shares under Section 2007 of that code may be taken only if the notice of the meeting states the general nature of the matter to be approved. (c) Notice need not be given of an adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is taken, except that if the adjournment is for more than 45 days or if after the adjournment a new record date is provided for the adjourned meeting, a notice of the adjourned meeting shall be given to each shareholder of record entitled to vote at that meeting. (d) Notice of any meeting of the shareholders shall be given personally, by first class mail, or by telegraph or other written communication, addressed to the shareholder at his address appearing on the books of the Corporation or given by him to the Corporation for the purpose of notice; or if no such address appears or is given, at the place where the principal executive office of the Corporation is located or by publication at least once in a newspaper of general circulation in the county in which the principal executive office is located. Notice shall be deemed to have been given at the time when delivered personally to the recipient, deposited in the mail, delivered to a common carrier for transmission to the recipient or sent by other means of written communication. An affidavit of the mailing or other means of giving notice may be executed by the Secretary, assistant secretary or any transfer agent of the Corporation giving the notice and shall be prima facie evidence of the giving of the notice. Such affidavits shall be filed and maintained in the minute books of the Corporation. (e) If any notice or report addressed to the shareholder at his address appearing on the books of the Corporation is returned to the Corporation by the United States Postal Service 9 10 marked to indicate that the United States Postal Service is unable to deliver the notice or report to the shareholder at such address, all future notices or reports shall be deemed to have been duly given without further mailing if the same shall be available for the shareholder upon his written demand at the principal executive office of the Corporation for a period of one year from the date of the giving of the notice or report to all other shareholders. (f) Only such business shall be conducted at an annual or special meeting of shareholders as shall have been properly brought before the meeting. For business to be properly brought before the meeting, it must be: (i) authorized by the Board of Directors and specified in the notice, or a supplemental notice, of the meeting, (ii) otherwise brought before the meeting by or at the direction of the Board of Directors or the chairman of the meeting, or (iii) otherwise properly brought before the meeting by a shareholder. For business to be properly brought before an annual or special meeting by a shareholder, the shareholder must have given written notice thereof to the Secretary, delivered or mailed to and received at the principal executive offices of the Corporation (A) in the case of an annual meeting (x) not less than 60 days nor more than 90 days prior to the meeting, or (y) if less than 70 days' notice of the meeting or prior public disclosure of the date of the meeting is given or made to shareholders, not later than the close of business on the tenth day following the day on which the notice of the meeting was mailed or, if earlier, the day on which such public disclosure was made and (B) in the case of a special meeting, as required by Section 3(b) above. A shareholder's notice to the Secretary shall set forth as to each item of business the shareholder proposes to bring before the meeting (1) a brief description of such item and the reasons for conducting such business at the meeting, (2) the name and address, as they appear on the Corporation's records, of shareholder proposing such business, (3) the class and number of shares of stock of the Corporation which are beneficially owned by the shareholder (for purposes of the regulations under Sections 13 and 14 of the Securities Exchange Act of 1934, as amended), and (4) any material interest of the shareholder in such business. No business shall be conducted at any annual or special meeting, except in accordance with the procedures set forth in this paragraph (f). The Chairman of the meeting at which any business proposed by a shareholder shall, if the facts warrant, determine and declare to the meeting that such business was not properly brought before the meeting and shall not be transacted. 10 11 Section 5. Record Date. (a) The Board of Directors may fix a time in the future as a record date for determination of the shareholders (1) entitled to notice of any meeting or to vote thereat, (2) entitled to give written consent to any corporate action without a meeting, (3) entitled to receive payment of any dividend or other distribution or allotment of any rights or (4) entitled to exercise any rights in respect of any other lawful action. The record date so fixed shall be not more than 60 nor less than 10 days prior to the date of any meeting of the shareholders nor more than 60 days prior to any other action. (b) In the event no record date is fixed: (1) The record date for determining the shareholders entitled to notice of or to vote at a meeting of shareholders shall be at the close of business on the business day next preceding the day on which notice is given or, if notice is waived, at the close of business on the business day next preceding the day on which the meeting is held. (2) The record date for determining shareholders entitled to give consent to corporate action in writing without a meeting, when no prior action by the Board of Directors has been taken, shall be the day on which the first written consent is given. (3) The record date for determining shareholders for any other purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto, or the 60th day prior to the date of such other action, whichever is later. (c) Only shareholders of record on the close of business on the record date are entitled to notice and to vote, to give written consent or to receive a dividend, distribution or allotment of rights or to exercise the rights, as the case may be, notwithstanding any transfer of any shares on the books of the Corporation after the record date. (d) A determination of shareholders of record entitled to notice of or to vote at a meeting of shareholders shall apply to any adjournment of the meeting unless the Board of Directors fixes a new record date for the adjourned meeting, but the Board shall fix a new record date if the meeting is adjourned for more than 45 days from the date set for the original meeting. 11 12 Section 6. Quorum. (a) A majority of the shares entitled to vote at a meeting of the shareholders, represented in person or by proxy, shall constitute a quorum for the transaction of business thereat. (b) The shareholders present at a duly called or held meeting at which a quorum is present may continue to transact business until adjournment notwithstanding the withdrawal of enough shareholders to leave less than a quorum, if any action taken (other than adjournment) is approved by at least a majority of the shares required to constitute a quorum. Section 7. Adjournment. Any meeting of the shareholders may be adjourned from time to time whether or not a quorum is present by the vote of a majority of the shares represented thereat either in person or by proxy. At the adjourned meeting the Corporation may transact any business which might have been transacted at the original meeting. Section 8. Validation of Actions Taken at Defectively Called, Noticed or Held Meetings. (a) The transactions of any meeting of the shareholders, however called and noticed, and wherever held, are as valid as though had at a meeting duly held after regular call and notice, if a quorum is present either in person or by proxy, and if, either before or after the meeting, each of the persons entitled to vote thereat, not present in person or by proxy, signs a written waiver of notice or a consent to the holding of the meeting or an approval of the minutes thereof. Any written waiver of notice shall comply with subdivision (f) of Section 601 of the Corporations Code of the State of California. All such waivers, consents and approvals shall be filed with the corporate records or made a part of the minutes of the meeting. (b) Attendance of a person at a meeting shall constitute a waiver of notice of and presence at such meeting, except (1) when the person objects, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened and (2) that attendance at a meeting is not a waiver of any right to object to the consideration of any matter required by the General Corporation Law of the State of California to be included in the notice but not so included, if such objection is expressly made at the meeting. Section 9. Voting for Election of Directors. (a) Except as provided in subdivision (c) of this section, the affirmative 12 13 vote of the majority of the shares represented and voting at a duly held meeting at which a quorum is present (which shares voting affirmatively also constitute at least a majority of the required quorum) shall be the act of the shareholders, unless the vote of a greater number is required by law or the Articles of Incorporation. (b) Every shareholder complying with subdivision (c) of this section and entitled to vote at any election of directors may cumulate his votes and give one candidate a number of votes equal to the number of directors to be elected, multiplied by the number of votes to which his shares are normally entitled, or distribute his votes on the same principle among as many candidates as he thinks fit. (c) No shareholder shall be entitled to cumulate his votes (i.e., cast for any candidate a number of votes greater than the number of votes which such shareholder normally is entitled to cast) unless the candidate's or candidates' names for which he desires to cumulate his votes have been placed in nomination prior to the voting and the shareholder has given notice at the meeting prior to the voting of his intention to cumulate his votes. If any one shareholder has given such notice, all shareholders may cumulate their votes for candidates in nomination. (d) Elections for directors may be by voice vote or by ballot unless any shareholder entitled to vote demands election by ballot at the meeting prior to the voting, in which case the vote shall be by ballot. (e) In any election of directors, the candidates receiving the highest number of affirmative votes of the shares entitled to be voted for them, up to the number of directors to be elected by such shares, are elected as directors. Section 10. Proxies. (a) Every person entitled to vote shares may authorize another person or persons to act with respect to such shares by a written proxy signed by him or his attorney-in-fact and filed with the Secretary of the Corporation. A proxy shall be deemed signed if the shareholder's name is placed on the proxy (whether by manual signature, typewriting, telegraphic transmission or otherwise) by him or his attorney-in-fact. (b) Any validly executed proxy, except a proxy which is irrevocable pursuant to subdivision (c) of this section, shall 13 14 continue in full force and effect until the expiration of the term specified therein or upon its earlier revocation by the person executing it prior to the vote pursuant thereto (1) by a writing delivered to the Corporation stating that it is revoked, (2) by written notice of death of the person executing the proxy, delivered to the Corporation, (3) by a subsequent proxy executed by the person executing the prior proxy and presented to the meeting or (4) as to any meeting by attendance at such meeting and voting in person by the person executing the proxy. No proxy shall be valid after the expiration of 11 months from the date thereof unless otherwise provided in the proxy. The date contained on the form of proxy shall be deemed to be the date of its execution. (c) A proxy which states that it is irrevocable is irrevocable for the period specified therein subject to the provisions of subdivisions (e) and (f) of Section 705 of the Corporations Code of the State of California. Section 11. Inspectors of Election. (a) In advance of any meeting of the shareholders, the Board of Directors may appoint either one or three persons (other than nominees for the office of director) as inspectors of election to act at such meeting or any adjournments thereof. If inspectors of election are not so appointed, or if any person so appointed fails to appear or refuses to act, the chairman of any such meeting may, and on the request of any shareholder or his proxy shall, appoint inspectors of election (or persons to replace those who so fail or refuse to act) at the meeting. If appointed at a meeting on the request of one or more shareholders or the proxies thereof, the majority of shares represented in person or by proxy shall determine whether one or three inspectors are to be appointed. (b) The duties of inspectors of election and the manner of performance thereof shall be as prescribed in subdivisions (b) and (c) of Section 707 of the Corporations Code of the State of California. Section 12. Action by Written Consent. (a) Subject to subdivisions (b) and (c) of this section, any action which may be taken at any annual or special meeting of the shareholders may be taken without a meeting, without a vote and without prior notice, if a consent in writing, setting forth the action so taken, is signed by the holders of outstanding shares having not less than the minimum number of votes which would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. All 14 15 such consents shall be filed with the Secretary of the Corporation and maintained with the corporate records. (b) Except for the election of a director by written consent to fill a vacancy (other than a vacancy created by removal), directors may be elected by written consent only by the unanimous written consent of all shares entitled to vote for the election of directors. In the case of an election of a director by written consent to fill a vacancy (other than a vacancy created by removal), any such election requires the consent of a majority of the outstanding shares entitled to vote for the election of directors. (c) Unless the consents of all shareholders entitled to vote have been solicited in writing, the secretary shall give prompt notice of the corporate action approved by the shareholders without a meeting. This notice shall be given in the manner specified in subdivision (d) of Section 4 of this Article III. In the case of approval of (1) contracts or transactions in which a director has a direct or indirect financial interest under Section 310 of the Corporations Code of California, (2) indemnification of agents of the corporation, under Section 317 of that code, (3) a reorganization of the corporation, under Section 1201 of that code, or (4) a distribution in dissolution other than in accordance with the rights of outstanding preferred shares, under Section 2007 of that code, notice of such approval shall be given at least ten (10) days before the consummation of any action authorized by that approval. (d) Any shareholder giving a written consent, or his proxyholders, or a transferee of the shares or a personal representative of the shareholder or their respective proxyholders, may revoke the consent by a writing received by the Corporation prior to the time that written consents of the number of shares required to authorize the proposed action have been filed with the Secretary of the Corporation, but may not do so thereafter. Such revocation is effective upon its receipt by the Secretary of the Corporation. ARTICLE IV Directors Section 1. Number of Directors. (a) The authorized number of directors shall depend upon the number of shareholders. If there is only one shareholder, then there will only be one 15 16 director. Whenever there is more than one shareholder, then there will be no less than five nor more than nine directors. The exact number of directors shall be fixed from time to time, within the limits specified in this subdivision, by an amendment of subdivision (b) of this section adopted by the Board of Directors. (b) The exact number of directors shall be one (1) until changed as provided in subdivision (a) of this section. Notwithstanding the preceding sentence, at all times while there is one (1) shareholder of the corporation, said shareholder may, without amending these By-laws, determine that there shall be five (5) directors. Said shareholder may elect the aforementioned five (5) directors by noticing a meeting of the shareholders of the corporation. (c) The maximum or minimum authorized number of directors may only be changed by an amendment of this section approved by the vote or written consent of a majority of the shareholders; provided, however, that an amendment reducing the minimum number to a number less than 5 shall not be adopted if the votes cast against its adoption at a meeting (or the shares not consenting in the case of action by written consent) exceed 16-2/3% of such outstanding shares; and provided, further, that in no case shall the stated maximum authorized number of directors exceed two times the stated minimum number of authorized directors minus one. Section 2. Election of Directors. Directors shall be elected at each annual meeting of the shareholders. Section 3. Term of Office. Each director, including a director elected to fill a vacancy, shall hold office until the expiration of the term for which he is elected and until a successor has been elected, and qualified. Section 4. Vacancies. (a) A vacancy in the Board of Directors exists whenever any authorized position of director is not then filled by a duly elected director, whether caused by death, resignation, removal, change in the authorized number of directors or otherwise. (b) Except for a vacancy created by the removal of a director, vacancies on the Board of Directors may be filled by a majority of the directors then in office, whether or not less than a quorum, or by a sole remaining director. A vacancy created by the removal of a director shall be filled only by a 16 17 person elected by a majority of the shareholders entitled to vote at a duly held meeting at which there is a quorum present or by the unanimous written consent of the holders of the outstanding shares entitled to vote at such a meeting. (c) The shareholders may elect a director at anytime to fill any vacancy not filled by the directors. Any such nomination shall comply with the requirements of Article III, Section 2(b) of these By-laws. Section 5. Removal. (a) The Board of Directors may declare vacant the office of a director who has been declared of unsound mind by an order of court or convicted of a felony. (b) Any or all of the directors may be removed without cause if such removal is approved by a majority of the outstanding shares entitled to vote; provided, however that no director may be removed (unless the entire Board of Directors is removed) if whenever the votes cast against his removal, or not consenting in writing to such removal, would be sufficient to elect such director if voted cumulatively at an election at which the same total number of votes were cast (or, if such action is taken by written consent, all shares entitled to vote were voted) and the entire number of directors authorized at the time of his most recent election were then being elected. (c) Any reduction of the authorized number of directors does not remove any director prior to the expiration of his term of office. Section 6. Resignation. Any director may resign effective upon giving written notice to the Chairman of the Board, the President, the Secretary or the Board of Directors of the Corporation, unless the notice specifies a later time for the effectiveness of such resignation. If the resignation is effective at a future time, a successor may be elected to take office when the resignation becomes effective. Section 7. Fees and Compensation. Directors may be paid for their services in such capacity a sum in such amounts, at such times and upon such conditions as may be determined from time to time by resolution of the Board of Directors and may be reimbursed for their expenses, if any, for attendance at each meeting of the Board. No such payments shall preclude any director from serving the Corporation in any other capacity and receiving compensation in any manner therefor. 17 18 ARTICLE V Committees of the Board of Directors Section 1. Designation of Committees. The Board of Directors may, by resolution adopted by a majority of the authorized number of directors, designate (1) one or more committees, each consisting of two or more directors and (2) one or more directors as alternate members of any committee, who may replace any absent member at any meeting thereof. Any member or alternate member of a committee shall serve at the pleasure of the Board. Section 2. Powers of Committees. Any committee, to the extent provided in the resolution of the Board of Directors designating such committee, shall have all the authority of the Board, except with respect to: (a) The approval of any action for which the General Corporation Law of the State of California also requires any action by the shareholders; (b) The filling of vacancies on the Board or in any committee thereof; (c) The fixing of compensation of the directors for serving on the Board or on any committee thereof; (d) The amendment or repeal of these By-laws or the adoption of new By-laws; (e) The amendment or repeal of any resolution of the Board which by its express terms is not so amendable or repealable; (f) A distribution to the shareholders of the Corporation, except at a rate or in a periodic amount or within a price range determined by the Board of Directors; or (g) The designation of other committees of the Board or the appointment of members or alternate members thereof. ARTICLE VI Meetings of the Board of Directors and Committees Thereof Section 1. Place and Meetings. Regular meetings of the Board of Directors shall be held at any place within or without the State of California which has been designated from time to time by the Board or, in the absence of such designation, at the 18 19 principal executive office of the Corporation. Special meetings of the Board shall be held either at any place within or without the State of California which has been designated in the notice of meeting or, if not stated in the notice or if there is no notice, at the principal executive office of the Corporation. Section 2. Organization Meeting. Immediately following each annual meeting of the shareholders the Board of Directors shall hold a regular meeting for the purpose of organization and the transaction of other business. Notice of any such meeting is not required. Section 3. Other Regular Meetings. Other regular meetings of the Board of Directors shall be held without call at such time as shall be designated from time to time by the Board. Notice of any such meeting is not required. Section 4. Special Meetings. Special meetings of the Board of Directors may be called at any time for any purpose or purposes by the Chairman of the Board or the President or any vice president or the Secretary or any two directors. Notice shall be given of any special meeting of the Board. Section 5. Notice of Special Meetings. Notice of the time and place of special meetings of the Board of Directors shall be delivered personally or by telephone to each director or sent to each director by first-class mail or telegraph, charges prepaid, addressed to each director at that director's address as shown on the records of the Corporation. Such notice shall be given four days prior to the holding of the special meeting if sent by mail or 48 hours prior to the holding thereof if delivered personally or given by telephone or telegraph. The notice or report shall be deemed to have been given at the time when delivered personally to the recipient or deposited in the mail or sent by other means of written communication. Notice of any special meeting of the Board or Directors need not specify the purpose thereof. Section 6. Waivers, Consents and Approvals. Notice of any meeting of the Board of Directors need not be given to any director who signs a waiver of notice or a consent to holding the meeting or an approval of the minutes thereof, whether before or after the meeting, or who attends the meeting without protesting, prior thereto or at its commencement, the lack of notice to him. All such waivers, consents and approvals shall be filed with the corporate records or made a part of the minutes of the meeting. 19 20 Section 7. Quorum; Action at Meetings; Telephone Meetings. (a) A majority of the authorized number of directors shall constitute a quorum for the transaction of business. Every act or decision done or made by a majority of the directors present is the act of the Board of Directors, unless action by a greater proportion of the directors is required by law or the Articles of Incorporation. (b) A meeting at which a quorum is initially present may continue to transact business notwithstanding the withdrawal of directors, if any action taken is approved by at least a majority of the required quorum for such meeting. (c) Members of the Board of Directors may participate in a meeting through use of conference telephone or similar communications equipment so long as all members participating in such meeting can hear one another. Section 8. Adjournment. A majority of the directors present, whether or not a quorum is present, may adjourn any meeting to another time and place. If the meeting is adjourned for more than 24 hours, notice of any adjournment to another time or place shall be given prior to the time of the adjourned meeting to the directors who were not present at the time of the adjournment. Section 9. Action Without a Meeting. Any action required or permitted to be taken by the Board of Directors may be taken without a meeting, if all members of the Board individually or collectively consent in writing to such action. Such written consent or consents shall be filed with the minutes of the proceedings of the Board. Such action by written consent shall have the same force and effect as a unanimous vote of such directors. Section 10. Meetings of and Action by Committees. The provisions of this Article apply to committees of the Board of Directors and action by such committees with such changes in the language of those provisions as are necessary to substitute the committee and its members for the Board and its members. ARTICLE VII Officers Section 1. Officers. The Corporation shall have as officers, a President, a Secretary and a Chief Financial Officer. The Treasurer is the chief financial officer of the 20 21 Corporation unless the Board of Directors has by resolution designated a vice president or other officer to be the chief financial officer. The Corporation may also have, at the discretion of the Board, a Chairman of the Board, one or more vice presidents, one or more assistant secretaries, one or more assistant treasurers and such other officers as may be appointed in accordance with the provisions of Section 3 of this Article. One person may hold two or more offices. Section 2. Election of Officers. The officers of the Corporation, except such officers as may be appointed in accordance with the provisions of Section 3 or Section 5 of this Article, shall be chosen by the Board of Directors. Section 3. Subordinate Officers, Etc. The Board of Directors may appoint by resolution, and may empower the Chairman of the Board, if there be such an officer, or the President, to appoint such other officers as the business of the Corporation may require, each of whom shall hold office for such period, have such authority and perform such duties as are determined from time to time by resolution of the Board or, in the absence of any such determination, as are provided in these By-laws. Any appointment of an officer shall be evidenced by a written instrument filed with the Secretary of the Corporation and maintained with the corporate records. Section 4. Removal and Resignation. (a) Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by the Board of Directors or, except in case of any officer chosen by the Board, by any officer upon whom such power of removal may be conferred by resolution of the Board. (b) Subject to the rights, if any, of the Corporation under any contract of employment, any officer may resign at any time effective upon giving written notice to the Chairman of the Board, President, any vice president or Secretary of the Corporation, unless the notice specifies a later time for the effectiveness of such resignation. Section 5. Vacancies. A vacancy in any office because of death, resignation, removal, disqualification or any other cause shall be filled in the manner prescribed in these By-laws for regular appointments to such office. Section 6. Chairman of the Board. If there is a Chairman of the Board, he shall, if present, preside at all meetings of the Board of Directors, exercise and perform such other powers 21 22 and duties as may be from time to time assigned to him by resolution of the Board or prescribed by these By-laws and, if there is no President, the Chairman of the Board shall be the chief executive officer of the Corporation and have the power and duties set forth in Section 7 of this Article. Section 7. President. Subject to such supervisory powers, if any, as may be given by these By-laws or the Board of Directors to the Chairman of the Board, if there be such an officer, the President shall be the chief executive officer and general manager of the Corporation and shall, subject to the control of the Board, have general supervision, direction and control of the business and affairs of the Corporation. He shall preside at all meetings of the shareholders and, in the absence of the Chairman of the Board, or if there be none, at all meetings of the Board. He shall have the general powers and duties of management usually vested in the office of president of a corporation, and shall have such other powers and duties as may be prescribed from time to time by resolution of the Board. Section 8. Vice President. In the absence or disability of the President, the vice presidents in order of their rank as fixed by the Board of Directors, or, if not ranked, the Vice President designated by the Board, shall perform all the duties of the President, and when so acting shall have all the powers of, and be subject to all the restrictions upon, the President. The vice presidents shall have such other powers and perform such other duties as from time to time may be prescribed for them respectively by the Board or as the President may from time to time delegate. Section 9. Secretary. (a) The Secretary shall keep or cause to be kept (1) the minute book, (2) the share register and (3) the seal, if any, of the Corporation. (b) The Secretary, an assistant secretary, or, if they are absent or unable to act, any other officer shall give, or cause to be given, notice of all meetings of the shareholders and of the Board of Directors required by these By-laws or by law to be given, and shall have such other powers and perform such other duties as may be prescribed from time to time by the Board of Directors or any committee of the Board of Directors. Section 10. Chief Financial Officer. (a) The Chief Financial Officer shall keep, or cause to be kept, the books and records of account of the Corporation. 22 23 (b) The Chief Financial Officer shall deposit all monies and other valuables in the name and to the credit of the Corporation with such depositories as may be designated from time to time by resolution of the Board of Directors. He shall disburse the funds of the Corporation as may be ordered by the Board of Directors, shall render to the President and the Board, whenever they request it, an account of all of his transactions as Chief Financial Officer and of the financial condition of the Corporation, and shall have such other powers and perform such other duties as may be prescribed from time to time by the Board or as the President may from time to time delegate. ARTICLE VIII Records and Reports Section 1. Minute Book. The Corporation shall keep or cause to be kept in written form at its principal executive office or such other place as the Board of Directors may order, a minute book which shall contain a record of all actions by its shareholders, Board or committees of the Board including the time, date and place of each meeting; whether a meeting is regular or special and, if special, how called; the manner of giving notice of each meeting and a copy thereof; the names of those present at each meeting of the Board or committees thereof; the number of shares present or represented at each meeting of the shareholders; the proceedings of all meetings; any written waivers of notice, consents to the holding of a meeting or approvals of the minutes thereof; and written consents for action without a meeting. Section 2. Share Register. The Corporation shall keep or cause to be kept at its principal executive office or, if so provided by resolution of the Board of Directors, at the Corporation's transfer agent or registrar, a share register, or a duplicate share register, which shall contain the names of the shareholders and their addresses, the number and classes of shares held by each, the number and date of certificates issued for the same and the number and date of cancellation of every certificate surrendered for cancellation. Section 3. Books and Records of Account. The Corporation shall keep or cause to be kept at its principal executive office or such other place as the Board of Directors may order, adequate and correct books and records of account. Section 4. By-laws. The Corporation shall keep at its principal executive office or, in the absence of such office in 23 24 the State of California, at its principal business office in the state, the original or a copy of the By-laws as amended to date. Section 5. Inspection of Records. The shareholders and directors of the Corporation shall have all of the rights to inspect the books and records of the Corporation that are specified in Section 213 and 1600 through 1602 of the Corporations Code of the State of California. Section 6. Annual Report to Shareholders. The Board of Directors shall cause an annual report to be sent to the shareholders not later than 120 days after the close of the fiscal year of the Corporation. Such report shall comply with the provisions of Section 1501 of the Corporations Code of the State of California and shall be sent in the manner specified in Section 4 (d) of Article III at least 15 days prior to the annual meeting of shareholders to be held during the next fiscal year. ARITCLE IX Miscellaneous Section 1. Checks, Drafts, Etc. All checks, drafts or other orders for payment of money, notes or other evidences of indebtedness, and any assignment or endorsement thereof, issued in the name of or payable to the Corporation, shall be signed or endorsed by such person or persons and in such manner as, from time to time, shall be determined by resolution of the Board of Directors. Section 2. Contracts, Etc. - How Executed. The Board of Directors, except as otherwise provided in these By-laws, may authorize any officer or officers, agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the Corporation, and such authority may be general or confined to specific instances; and, unless so authorized or ratified by the Board, no officer, employee or other agent shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or to any amount. Section 3. Certificates of Stock. A certificate or certificates for shares of the capital stock of the Corporation shall be issued to each shareholder when the shares are fully paid or the Board of Directors may authorize the issuance of certificates for shares as partly paid provided that these certificates shall conspicuously state the amount of the 24 25 consideration to be paid for them and the amount already paid. All certificates shall be signed in the name of the Corporation by the Chairman of the Board or the President or a vice president and by the Chief Financial Officer or an assistant treasurer or the Secretary or an assistant secretary, certifying the number of shares and the class or series thereof owned by the shareholder. Any or all of the signatures on a certificate may be by facsimile signature. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such person were an officer, transfer agent or registrar at the date of issue. Section 4. Lost Certificates. Except as provided in this section, no new certificate for shares shall be issued in lieu of an old certificate unless the latter is surrendered to the Corporation and canceled at the same time. The Board of Directors may in case any share certificate or certificate for any other security is lost, stolen or destroyed, authorize the issuance of a new certificate in lieu thereof, upon such terms and conditions as the Board may require, including provision for indemnification of the Corporation secured by a bond or other adequate security sufficient to protect the Corporation against any claim that may be made against it, including any expense or liability, on account of the alleged loss, theft or destruction of such certificate or the issuance of such new certificate. Section 5. Representation of Shares of Other Corporations. Any person designated by resolution of the Board of Directors or, in the absence of such designation, the Chairman of the Board, the President or any vice president or the Secretary, or any other person authorized by any of the foregoing, is authorized to vote on behalf of the Corporation any and all shares of any other corporation or corporations, foreign or domestic, owned by the Corporation. Section 6. Construction and Definitions. Unless the context otherwise requires, the general provisions, rules of construction and definitions contained in the Corporations Code of the State of California shall govern the construction of these By-laws. Section 7. Mandatory Indemnification of Directors. The Corporation shall, to the maximum extent and in the manner permitted by the California Corporations Code ("Code"), indemnify each of its directors against expenses (as defined in Section 317(a) of the Code), judgments, fines, settlements, and other amounts actually and reasonably incurred in connection with any proceeding (as defined in 25 26 Section 317 (a) of the Code), arising by reason of the fact that such person is or was an agent of the Corporation. For purposes of this Article IX, a "director" of the Corporation includes any person (i) who is or was a director of the Corporation, (ii) who is or was serving at the request of the Corporation as a director of another Corporation, partnership, joint venture, trust or other enterprise, or (iii) who was a director of a corporation which was a predecessor corporation of the Corporation or of another enterprise at the request of such predecessor corporation. Section 8. Permissive Indemnification. The Corporation shall have the power, to the extent and in the manner permitted by the Code, to indemnify each of its officers, employees and agents against expenses (as defined in Section 317(a) of the Code), judgments, fines, settlements, and other amounts actually and reasonable incurred in connection with any proceeding (as defined in Section 317(a) of the Code), arising by reason of the fact that such person is or was an agent of the Corporation. For purposes of this Article IX, an "employee" or "agent" of the Corporation (other than a director, includes any person (i) who is or was an employee or agent of the Corporation, (ii) who is or was serving at the request of the Corporation as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise, or (iii) who was an employee or agent of the Corporation which was a predecessor corporation of the Corporation or of another enterprise at the request of such predecessor corporation. Section 9. Payment of Expenses in Advance. Expenses incurred in defending any civil or criminal action or proceeding for which indemnification is required pursuant to Section 7 or for which indemnification is permitted pursuant to Section 8 following authorization thereof by the Board of Directors, in the case of directors shall and in the case of other agents of the corporation entitled to indemnification may, be paid by the corporation in advance of the final disposition of such action or proceeding upon receipt of an undertaking by or on behalf of the indemnified party to repay such amount if it shall ultimately be determined that the indemnified party is not entitled to be indemnified as authorized in this Article IX. Section 10. Indemnity Not Exclusive. The indemnification provided by this Article IX shall not be deemed exclusive of any other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of shareholders or 26 27 disinterested directors or otherwise, both as to action in an official capacity and as to action in another capacity while holding such office, to the extent that such additional rights to indemnification are authorized in the Articles of Incorporation. Section 11. Insurance Indemnification. The Corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was an agent of the Corporation against any liability asserted against or incurred by such person in such capacity or arising out of such person's status as such, whether or not the Corporation would have the power to indemnify him against such liability under the provisions of this Article IX. Section 12. Conflicts. No indemnification or advance shall be made under this Article IX, except where such indemnification or advance is mandated by law or the order, judgment or decree of any court of competent jurisdiction, in any circumstance where it appears: (1) That it would be inconsistent with a provision of the Articles of Incorporation, these By-laws, a resolution of the shareholders or an agreement in effect at the time of the accrual of the alleged cause of the action asserted in the proceeding in which the expenses were incurred or other amounts were paid, which prohibits or otherwise limits indemnification; or (2) That it would be inconsistent with any condition expressly imposed by a court in approving a settlement. ARTICLE X Amendments Section 1. Amendments. New By-laws may be adopted or these By-laws may be amended or repealed by the affirmative vote or written consent of a majority of the outstanding shares entitled to vote. Subject to the next preceding sentence, By-laws (other than a bylaw or amendment thereof specifying or changing a fixed number of directors or the maximum or minimum number, or changing from fixed to a variable board or vice versa) may be adopted, amended or repealed by the Board of Directors. 27 EX-10.25 3 ADDENDUM TWO TO LEASE AGREEMENT 1 Exhibit 10.25 ADDENDUM TWO TO LEASE AGREEMENT FOR A GAMMA KNIFE UNIT This ADDENDUM TWO TO LEASE AGREEMENT FOR A GAMMA KNIFE UNIT (this "Addendum") is effective October 1, 1999 between Hoag Memorial Hospital Presbyterian, a California Corporation ("Hospital"), and GK Financing, LLC, a California limited liability company ("GKF"). RECITALS WHEREAS, on October 31, 1996, GKF and Hospital executed a Lease Agreement for a Gamma Knife Unit (the "Original Lease"); WHEREAS, the parties desire to amend the terms and provisions of the Original Lease as set forth herein. NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: AGREEMENT 1. DEFINED TERMS. Unless otherwise defined herein, the capitalized terms used herein shall have the same meaning set forth in the Original Lease. 2. ADDENDUM EXTENSION. The Addendum to Lease Agreement for a Gamma Knife unit effective December 1, 1998 shall be extended for a one (1) year period from December 1, 1999 through November 30, 2000. 3. MODIFICATION TO THE PER PROCEDURE PAYMENTS. Hospital has requested GKF to discount the fee per procedure payments for Gamma Knife procedures set forth in Paragraph 6 of the Original Lease to allow Hospital to perform charity care for uninsured persons who meet state-adopted standards of indigency, and with respect to certain Medi-Cal and Medi-Cal/Cal Optima beneficiaries (the "Discounted Procedures"). GKF agrees to discount the per procedure payments described in Paragraph 6 of the Original Lease for Discounted Procedures by waiving the applicable payment for such Discounted Procedure (the "Discount"), provided that (i) * ; (ii) the Discount may only be claimed for Gamma Knife procedures performed by Hospital between October 1, 1999 and September 30, 2000; and (iii) Hospital must fully and accurately report the Discount in its applicable cost report or other claims for payment to the Medicare or Medi-Cal program in the same fiscal year in which the Discount is earned. Hospital shall be solely responsible (and GKF shall not in any manner be or become responsible) to determine (a) 2 whether any person is entitled to a Discounted Procedure, and (b) if more than one (1) person is entitled to a Discounted Procedure, who shall receive the Discounted Procedure. At or prior to the time payment for the Discounted Procedure is required, Hospital shall provide GKF with reasonable written documentation that the requirements for a Discounted Procedure have been met and evidencing Hospital's compliance with the requirements herein. If the Discount is entitled to be claimed by Hospital as determined by GKF in its reasonable discretion, GKF shall report such discount on its invoice or statement submitted to Hospital. 4. TERM OF AMENDMENT. Section 3 of this addendum shall be in effect for a one year period, October 1, 1999, though September 30, 2000. 5. FULL FORCE AND EFFECT. Except as otherwise amended hereby or provided herein, all of the terms and provisions of the Original Lease shall remain in full force and effect. IN WITNESS WHEREOF, the parties have executed this Addendum effective as of the date first written above. "HOSPITAL" Hoag Memorial Hospital Presbyterian BY: /s/ Robert Braithwaite ------------------------------------------ Robert Braithwaite, Vice President "GKF" GK Financing, LLC BY: /s/ Craig K. Tagawa ------------------------------------------ Craig K. Tagawa, Chief Executive Officer EX-10.26 4 LEASE AGREEMENT FOR GAMMA KNIFE UNIT 1 Exhibit 10.26 LEASE AGREEMENT FOR A GAMMA KNIFE UNIT THIS AGREEMENT FOR A GAMMA KNIFE UNIT on May 28, 1999, (hereinafter, referred to as the "Agreement") is entered into between GK Financing, LLC, a California Limited Liability Company, (hereinafter referred to as "GKF"), and Froedtert Memorial Lutheran Hospital, a non-profit Wisconsin corporation, (hereinafter referred to as "Medical Center"). R E C I T A L S WHEREAS, Medical Center wants to lease a Leksell Stereotactic Gamma Unit Manufactured by Elekta Instruments, Inc., (hereinafter referred to as the "Equipment"); and WHEREAS, GKF is willing to lease the Equipment which GKF has acquired from Elekta Instruments, Inc., a Georgia corporation (hereinafter referred to as "Elekta"), to Medical Center, pursuant to the terms and conditions of this Agreement. NOW, therefore, in consideration of the foregoing premises and the promises contained herein, the parties hereto hereby agree as follows: 1. Execution of LGK Agreement by and between Medical Center and Elekta. Medical Center agrees that simultaneously with the execution of this Agreement it shall execute that certain LGK Agreement with Elekta, (hereinafter referred to as the "LGK Agreement"), a copy of which is attached hereto as Exhibit A and incorporated herein by this reference. Medical Center agrees to fulfill all of its obligations under the LGK Agreement and acknowledges that GKF is a third party beneficiary of the LGK Agreement. Medical Center shall indemnify and hold harmless GKF in the event that GKF suffers any loss, damage, claim or expense (including reasonable attorneys' fees) solely as a result of Medical Center's breach or alleged breach of the LGK Agreement. 2. Delivery of the Equipment and Site preparation. GKF shall arrange to have the Equipment delivered to Medical Center, at Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Avenue, Milwaukee, Wisconsin, 53226 (the "Site") in coordination with Elekta. Medical Center shall provide a Site, at its own expense, in accordance with all of the Equipment manufacturer's (Elekta's) guidelines, specifications, technical instruments and Site Planning Criteria (which Site Planning Criteria are attached hereto as Exhibit B and incorporated herein by this reference), which criteria shall include Elekta's estimated delivery schedule when and as received by GKF, on Medical Center controlled property (The "Site") for the proper performance of Gamma Knife procedures. Site location shall - 1 - 2 be reasonably acceptable to GKF. Medical Center shall prepare at its sole cost and expense the requisite site plans and specifications and shall submit them to Elekta and GKF for approval. Medical Center shall obtain, in a timely manner, a User License from the Nuclear Regulatory Commission and/or appropriate state agency authorizing it to take possession of the Cobalt Supply and shall obtain such other licenses, permits, approvals, consents and authorizations, which may be required by local governmental or other regulatory agencies for the Site, its preparation, the charging of the Equipment with its Cobalt Supply, the conduct of Acceptance Tests, and the use of the Equipment all as more fully set forth in the LGK Agreement. 3. Commencement of Term. The Term (hereinafter defined) of this Agreement shall commence upon successful completion of the Acceptance Tests and the performance of the first clinical Gamma Knife procedure at the Site (the "Commencement Date"). Medical Center shall become liable to GKF for the payments referred to in Paragraph 6 hereinbelow upon the Commencement Date. 4. Costs of Site Preparation; Costs of Installation. Medical Center's obligations shall include preparation of plans and specifications for the construction and preparation of the Site in such form as will result in the Site, when constructed in accordance with such plans and specifications, being in full compliance with Elekta's Site Planning Criteria. Medical Center shall at its own expense and risk, prepare, construct and make ready the Site as necessary, for the installation of the Equipment, including, but not limited to, providing any temporary and/or permanent shielding for the charging of the equipment and its use, selecting and preparing a proper foundation for the Equipment and for such shielding and walls, as well as proper alignment of the Site and wiring. Medical Center shall be financially responsible for the positioning of the Equipment on its foundation at the Site. Medical Center shall also at its own expense select, purchase and install all radiation monitoring equipment and devices, safety circuits and radiation warning signs needed for the Equipment at the Site, required by all applicable federal, state and local laws and regulations. Upon completion of the Site, Medical Center shall warrant that the Site will be safe and suitable for its use of the Equipment. Medical Center shall fully indemnify and hold harmless GKF from any and all loss, liability, damage, expense or claim (including attorneys' fees) which GKF may suffer and incur and which relate to the Site and the Equipment's positioning thereon. Medical Center shall be responsible for any damage to the Equipment caused by (a) defects in construction of the Site or defects in the positioning of the Equipment at the Site by Medical Center; (b) defects arising out of materials or parts provided, modified or designed by Medical Center with respect to the Site; or (c) negligent or intentional acts of - 2 - 3 omission or commission by Medical Center or any of its officers, agents, physicians, and employees in connection with the Site preparation or operation of the Equipment at the Site. Medical Center warrants that it shall utilize its best efforts to fulfill on an expeditious basis its obligations under this Paragraph 4. Medical Center further warrants that it shall on a regular basis keep GKF informed of Medical Center's progress in fulfilling its obligations pursuant to this Paragraph 4. GKF shall deliver the Equipment to the Medical Center's designated loading dock on July 1, 1999. Should GKF fail to deliver the Equipment no later than thirty (30) days after July 1, 1999 GKF shall pay Medical Center $100,000. Should Medical Center not have all site preparations completed by the delivery date specified by a separate agreement plus a sixty (60) day grace period such that the site is acceptable for positioning and installation of the equipment, Medical Center shall reimburse GKF at an interest rate of Bank of America's prime rate plus 2% on GKF's equipment cost until the Site is prepared to allow positioning and installation of the equipment. 5. Term of the Equipment. GKF agrees to provide to Medical Center the Equipment pursuant to the terms of this Agreement, for a term of ten (10) years from the Commencement Date as described in Paragraph 3 hereinabove (the "Term"), unless terminated earlier as provided herein. 6. Per Procedure Payments. Medical Center shall pay to GKF a per procedure payment of for the use of the Equipment pursuant to Exhibit I. A procedure shall be defined as a single patient treatment session that may include one or more isocenters during that session. Medical Center shall be billed on the fifteenth (15th) and the last day of each month for the actual number of procedures performed during the first and second half of the month, respectively. Medical Center shall pay the procedures invoiced within thirty (30) days after receipt of the invoice. Interest shall begin to accrue at the rate of 1-1/2% per month on all invoices remaining unpaid after 45 days. After twenty four (24) months of service, and every twelve (12) months thereafter, the parties agree to review and renegotiate the payment provisions of this paragraph, including consideration of payment as a percentage of the Medical Center's reimbursement (although GKF shall be under no obligation to change such payment provisions). 7. Use of the Equipment. The Equipment may be used by Medical Center only at the location stated above and shall not be removed therefrom. Medical Center shall not assign or sublease the Equipment or its rights hereunder without the prior written consent of GKF which consent shall not be unreasonably withheld. Medical Center may, however, permit the equipment to be used by trained personnel that are not employees of Medical Center. No permitted assignment or sublease shall relieve Medical Center of any of its obligations hereunder. Medical Center shall not use nor permit the Equipment to be used in any manner nor for any purpose for which, in the opinion of Elekta, the Equipment is not - 3 - 4 designed or reasonably suitable. Medical Center shall not permit any liens, whether voluntary or involuntary, to attach to the Equipment, without the prior written consent of GKF. Medical Center shall have no interest in the Equipment other than the rights acquired as a lessee hereunder and the Equipment shall remain the property of GKF regardless of the manner in which it may be installed or attached at the Site. Medical Center shall, at GKF's reasonable request, affix to the Equipment tags, decals, or plates furnished by GKF, indicating GKF's ownership of the Equipment. 8. Additional Covenants of Medical Center. In addition to the other covenants made by Medical Center, Medical Center shall at its own cost and expense: (a) Provide properly trained professional, technical and support personnel and supplies required for the proper performance of medical procedures utilizing the Equipment (subject to Elekta's obligation to provide training of Medical Center personnel, as provided in the LGK Agreement). (b) Assume all medical and financial responsibility for the overseers' monitoring of all patients' medical condition and treatment. (c) Fully comply with all of its obligations under the LGK Agreement. (d) Indemnify GKF as herein provided: (i) Medical Center hereby agrees to fully indemnify and/or reimburse (including reasonable attorneys' fees) GKF on a prompt basis for any and all damage to the Equipment (including any violations by Medical Center, its agents, officers, physicians, employees, successors and assigns of the Service Agreement described in Paragraph 15 hereof) to the extent such damages are caused by the negligent or wrongful acts or omissions of Medical Center, its agents, officers, physicians and employees and are in excess of insurance proceeds recovered by GKF. In the event the Equipment is destroyed or rendered unusable, this indemnification shall extend up to (but not exceed) the full replacement value of the Equipment at the time of its destruction less salvage value, if any. (ii) Medical Center hereby further agrees to indemnify and hold GKF, its agents, officers, employees, successors and assigns, harmless from and against any and all claims, liabilities, obligations, losses, damages, injuries, penalties, actions, costs and expenses (including reasonable attorneys' fees) for all events and/or occurrences described in Article 7.3 of the LGK Agreement to the same extent that Medical Center agrees to indemnify Elekta thereunder. Medical Center further agrees to fully indemnify and hold harmless GKF for any loss, damage, claim, or expense (including reasonable attorneys' fees) GKF may suffer or incur as a result of Medical Center's breach or breach alleged in litigation with regard to the LGK Agreement. GKF shall give prompt notice to Medical Center of any claim and Medical Center at its option and expense may assume the primary defense of the claim. Any compromise or settlement shall require the prior written consent of GKF which consent shall not be unreasonable withheld. - 4 - 5 (e) Provide reasonable and customary marketing materials (i.e. brochures, announcements, etc.), marketing support, and an administrative and physician (i.e. seminars by neurosurgeons and radiation oncologists to referring physicians, etc.) commitment to this clinical service. Medical Center and GKF personnel shall jointly develop and agree upon a marketing plan and budget. Not less than ninety (90) days prior to the First Procedure Date and the commencement of each succeeding twelve (12) month period of the Term. As funds are expended by Medical Center shall submit invoices (together with documentary evidence supporting the invoices) for its expenditures and, promptly following the receipt of such invoices, GKF shall reimburse Medical Center * of the expenditures up to the limit of * , unless said limit is waived by GKF. 9. Additional Covenants, Representations and Warranties of GKF. In addition to the other covenants, representations and warranties, made by GKF in this Agreement: (a) GKF represents and warrants that GKF has full power and authority to enter into this Agreement, and that this Agreement does not and will not violate any agreement, contract or instrument binding upon GKF. (b) GKF represents and warrants to Medical Center that, upon delivery of the Equipment to Medical Center, GKF shall use its best faith efforts to require that Elekta meets its contractual obligations to GKF and in putting the Equipment, as soon as possible, into good, safe and serviceable condition and fit for its intended use in accordance with the manufacturer's specifications, guidelines and field modification instructions. (c) GKF represents and warrants that throughout the term of this Agreement, subject to the second paragraph of section 10 below it has good marketable title to the equipment, and Medical Center shall enjoy the use of the Equipment, free of the rights of any other persons except for those rights reserved by GKF or granted to Elekta under the LGK Agreement. (d) During the entire term of this agreement and subsequent extension thereof, GKF shall maintain in full force and effect: (i) the Service Agreement referenced in Paragraph 15 hereof; and (ii) any other service or other agreements required to fulfill GKF's obligations to Medical Center under this Agreement. GKF represents and warrants that during the entire term of this agreement and any subsequent extensions thereof, that it will fully pursue any and all remedies it may have against Elekta under the Service Agreement to insure that Elekta fully performs its obligations under the Service Agreement and that the Equipment will be in conformity with Elekta's warranties so that it is free from defects in design, materials, and workmanship which result in noncompliance with the specifications and/or Elekta's warranties to GKF. In no event, however, shall the warranty obligations of GKF to Medical Center with respect to the Equipment be greater or more extensive than Elekta's warranty obligations to GKF with respect to the Equipment. - 5 - 6 10. Ownership/Title. It is expressly understood that Medical Center shall acquire no right, title or interest in or to the Equipment, other than the right to the possession and use of the same in accordance with the terms of this Agreement. GKF may at its sole discretion finance the Equipment. Financing may be in the form of an installment loan or a capitalized lease or other commercially available debt instrument. Should GKF finance the Equipment through an installment loan, GKF shall be required to provide the Equipment as collateral against the loan. Should GKF finance the Equipment through a capitalized lease title shall vest with the lessor until GKF exercises its buy-out option. In addition, should GKF finance the Equipment, said agreement may be used as collateral against the loan. In all of the foregoing situations, GKF shall use its best efforts to cause the entity financing the equipment to agree not to disturb the rights of the Medical Center under this Agreement so long as the Medical Center does not default on its obligations hereunder. In the event the financial entity forecloses on GKF's interest in the equipment of this Agreement and said foreclosure is not cured within 45 days and the financing entity elects not to assume GKF's obligations, Medical Center may elect to purchase the equipment for its fair market value or principal balance, whichever is higher. 11. Cost of Use of the Equipment. Except as is otherwise provided herein, Medical Center shall bear the entire cost of using the Equipment during the Term of this Agreement. This shall include, but not be limited to, providing trained professionals, technical and support personnel and supplies to properly operate the Equipment. Medical Center shall be fully responsible and liable for all acts and/or omissions of such professional, technical and support personnel. 12. Taxes. GKF shall pay any personal property taxes levied against the Equipment and any other taxes or governmental fees or assessments, however denoted, whether of the federal government, any state government or any local government, levied or based on this Agreement or the use of the Equipment except for those taxes, if any, pertaining to the gross income or gross receipts of Medical Center. 13. Maintenance and Inspections. GKF agrees to exercise due and proper care in the maintenance of the Equipment and to keep the Equipment in a good state of repair, reasonable wear and tear excepted. Medical Center shall be responsible for all damage to the Equipment caused by the misuse, negligence, improper use or other intentional or negligent acts or omissions of Medical Center's employees, officers, agents, and physicians. GKF (and Elekta) shall have the right of access to the Equipment for the purpose of inspecting and repairing the same at all reasonable times and upon reasonable prior written notice and shall use all reasonable efforts not to interfere with Medical Center's use of the Equipment. In the event the Equipment is improperly used by Medical Center or its employees, agents, officers, and physicians, GKF may service or repair the same as - 6 - 7 needed and such expense shall be paid by Medical Center, unless the repair is covered by the Service Agreement described in Paragraph 15 hereof. Any work so performed by or in the service or maintenance of the Equipment as a result of Medical Center's failure or neglect to do so shall not deprive GKF of any of its rights, remedies or actions against Medical Center for damages caused by such failure or neglect. If, thirty (30) days after giving of written notice by Medical Center, GKF fails to make the repairs it is required to make under this Agreement, Medical Center may make the repairs. GKF shall reimburse Medical Center for the cost of the repairs within thirty (30) days, following receipt of Medical Center's invoice. 14. Equipment Modifications/Additions/Upgrades. The parties agree that the necessity and financial responsibility for modifications/additions/upgrades to the Equipment, including the reloading of the Cobalt-60 source, shall be discussed and mutually decided by GKF and Medical Center. If GKF and Medical Center agree to reload the Cobalt-60 source (in approximately year 8 of the initial term), GKF shall be responsible for the expenses relate to the Cobalt-60 reloading and Medical Center shall be responsible for any site costs associated with the Cobalt-60 reload. If the reloading of the Equipment occurs, the original term shall be extended for 8 years less the number of years remaining in the original term. GKF shall reimburse Medical Center for the cost of the repairs within thirty (30) days, following receipt of Medical Center's invoice. 15. Service Agreement. GKF warrants that it shall simultaneously with the execution of this Agreement enter into a Service Agreement with Elekta in the form of Exhibit C attached to this Agreement. 16. Termination If, after the initial twenty-four (24) month period of service, and subsequent 12 month periods of service, Medical Center does not provide GKF with a reasonable economic justification to continue providing Gamma Knife services hereunder, then and in that event, GKF shall have the option of terminating this Agreement upon the giving of written notice to Medical Center of said termination not less than ninety (90) days prior to GKF's designated termination date. 17. Options to Extend Agreement. (a) Medical Center shall have the option at the end of the ten (10) year initial Term to: (i) Renegotiate this Agreement for a five (5) year renewal term. (ii) Terminate this Agreement. If Medical Center terminates this Agreement at the end of the initial term, GKF shall remove the Gamma Knife within an - 7 - 8 agreed upon period of time after the expiration of the ten (10) year initial Term not in excess of 90 days. Medical Center shall exercise one (1) of the two (2) options referred to above, by mailing an irrevocable written notice thereof to GKF at Four Embarcadero Center, Suite 3620, San Francisco, California, 94111, by registered mail, postmarked on or before the end of the ninth (9th) year of the ten (10) year initial Term of this Agreement. Any such notice shall be sufficient if it states in substance that Medical Center elects to exercise its option and states which of the two (2) options referred to above Medical Center is exercising. 18. No Warranties by GKF. Medical Center warrants that as of the Commencement Date, it shall have (a) thoroughly inspected the Equipment; (b) determined for itself that all items of the Equipment are of a size, design, capacity and manufacture selected by it; and (c) satisfied itself that to the best of its knowledge the Equipment is suitable for Medical Center's stated purposes. GKF SUPPLIES THE EQUIPMENT "AS IS" AND NOT BEING THE MANUFACTURER OF THE EQUIPMENT OR THE MANUFACTURER'S AGENT, MAKES NO WARRANTY OR REPRESENTATION, EITHER EXPRESSED OR IMPLIED, AS TO THE EQUIPMENT'S MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, DESIGN, CONDITION, DURABILITY, CAPACITY, MATERIAL OR WORKMANSHIP OR AS TO PATENT INFRINGEMENT OR THE LIKE, it being agreed that all such risks as between GKF and Medical Center, shall be borne by Medical Center. Medical Center agrees to look solely to the manufacturer (Elekta) or to suppliers of the Equipment (and its software) for any and all warranty claims. Any and all warranties made by Elekta will be in its good faith best efforts enforced by GKF on behalf of Medical Center during the ten (10) year initial Term hereof. Medical Center agrees that GKF shall not be responsible for the delivery, installation, or operation of the Equipment or for any delay or inadequacy of any or all of the foregoing. GKF shall not be responsible for any direct or indirect consequential loss or damage resulting from the installation, operation or use of the Equipment or otherwise. Medical Center expressly waives any right to hold GKF liable hereunder for any claims, demands and liabilities arising out of or in connection with the design, manufacture, possession or operation of the Equipment. 19. Events of Default and Remedies. The occurrence of any one of the following shall constitute an Event of Default hereunder: (a) Medical Center fails to pay any installment of semi-monthly procedure payments when due when such default continues for a period of thirty (30) days after notice thereof from GKF or its assignee is given to Medical Center. (b) Medical Center attempts to remove, sell, transfer, encumber, sublet or part with possession of the Equipment or any items thereof, except as expressly permitted herein; - 8 - 9 (c) Medical Center shall fail to observe or perform any of the other obligations required to be observed or performed by Medical Center hereunder and such failure shall continue uncured for thirty (30) days after written notice thereof to Medical Center by GKF provided, however, that if the nature of the default is such that it cannot reasonably be cured within the thirty (30) day period, the Medical Center shall not be deemed to be in default if it shall commence to cure the default within the thirty (30) day period and diligently effect the cure within a period not exceeding an additional thirty (30) days; (d) Medical Center ceases doing business as a going concern, makes an assignment for the benefit of creditors, admits in writing its inability to pay its debts as they become due, files a voluntary petition in bankruptcy, is adjudicated a bankrupt or an insolvent, files a petition seeking for itself any reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar arrangement under any present or future statute, law or regulation or files an answer admitting the material allegations of a petition filed against it in any such proceeding, consents to or acquiesces in the appointment of a trustee, receiver, or liquidator of it or of all or any substantial part of its assets or properties, or it or its shareholders shall take any action looking to its dissolution or liquidation. (e) Within sixty (60) days after the commencement of any proceedings against Medical Center seeking reorganization, arrangement, readjustment, liquidation, dissolution or similar relief under any present or future statute, law or regulation, such proceedings shall not have been dismissed, or if within thirty (30) days after the appointment without Medical Center's consent or acquiescence of any trustee, receiver or liquidator of it or of all or any substantial part of its assets and properties, such appointment shall not be vacated. Upon the occurrence of an Event of Default, GKF may at its option do any or all of the following: (i) by notice to Medical Center, terminate this Agreement as to the Equipment in default, wherever situated, and for such purposes, enter upon the Site without liability for so doing or GKF may cause Medical Center and Medical Center hereby agrees to return the Equipment to GKF at Medical Center's sole cost and expense; (ii) recover from, as liquidated damages for the loss of the bargain and not as a penalty, an amount equal to the present value of the unpaid estimated future lease payments by Medical Center to GKF through the end of the Agreement term discounted at the rate of nine percent (9%), which payment shall become immediately due and payable. Unpaid estimated future lease payments shall be based on the prior 12 months lease payments with a five percent (5%) increase; (iii) sell, dispose of, hold, use or lease the Equipment in default, as GKF in its sole discretion may determine (and GKF shall not be obligated to give preference to the sale, lease or other disposition of the Equipment over the sale, lease or other disposition of similar Equipment owned or leased by GKF). In any event, Medical Center shall, without further demand, pay to GKF an amount equal to all sums due and - 9 - 10 payable for all periods up to and including the date on which GKF had declared this Agreement to be in default. In the event, that Medical Center shall have paid to GKF the liquidated damages referred to in (iii) above, GKF hereby agrees to pay to Medical Center promptly after receipt thereof, all rentals or proceeds received from the reletting or sale of the Equipment during the balance of the ten (10) year initial Term (after deduction of all expenses incurred by GKF; said amount never to exceed the amount of the liquidated damages paid by Medical Center). Medical Center agrees that GKF shall have no obligation to sell the Equipment. Medical Center shall in any event remain fully liable for reasonable damages as provided by law for all costs and expenses incurred by GKF on account of such default, including but not limited to, all court costs and reasonable attorneys' fees. Medical Center hereby agrees that, in any event, it shall be liable for any deficiency after any sale, lease or other disposition of the Equipment by GKF. The rights afforded GKF hereunder shall not be deemed to be exclusive, but shall be in addition to any other rights or remedies provided by law. 20. Insurance. (a) During the ten (10) year initial Term of this Agreement (and any successive terms) GKF shall, at its own cost and expense, keep in effect an all risk and hazard insurance policy covering the Equipment. The all risk and hazard insurance policy shall be for an amount not less than the replacement cost of the Equipment. During the ten (10) year initial Term of this Agreement, Medical Center shall, at its own cost and expense keep in effect public liability and professional liability insurance policies concerning the operation of the Equipment by Medical Center. Said policies shall be in the amounts of not less than $1,000,000 per occurrence and $5,000,000 in aggregate per year. Medical Center and GKF, their successors and assigns, shall be named as additional insureds and/or loss payees on the insurance policies maintained hereunder by the other party. Evidence of such insurance coverages shall be furnished by both parties to the other party upon written request, by no later than the Commencement Date. (b) If the Equipment is rendered unusable as a result of any physical damage to, or destruction of, the Equipment, Medical Center shall give to GKF prompt notice. GKF shall determine, within thirty (30) days after the date of occurrence of such damage or destruction, whether the Equipment can be repaired. In the event GKF determines that the Equipment cannot be repaired, subject to section 8(d), GKF at its sole cost and expense shall promptly replace the Equipment. This Agreement shall continue in full force and effect as though such damage or destruction had not occurred except that the term of the Agreement shall be extended by the time the Equipment was rendered unusable. In the event GKF determines that the Equipment can be repaired, GKF shall cause the Equipment to be promptly repaired, subject to section 8(d). - 10 - 11 21. Notices. Any notices required under this Agreement shall be sent in writing and shall be deemed to have been duly given if delivered by hand or mailed by certified or registered mail to the following addresses: To GKF: Chief Executive Officer Four Embarcadero Center, Suite 3620 San Francisco, CA 94111 To Medical Center: Chief Executive Officer Froedtert Memorial Lutheran Hospital 9200 W. Wisconsin Avenue Milwaukee, WI 53226 Or to such other addresses as either party may specify for the reception of notice from time to time in writing to the other party. Any such notice shall be effective only when actually received by the party to whom addressed. 22. Integration/Supersedure. This Agreement contains the full and entire Agreement between the parties hereto, and no oral or written understanding is of any force or effect whatsoever unless expressly contained in a writing executed subsequent to the date of this Agreement. 23. Waivers. To the extent that either party fails or chooses not to pursue any of its remedies under this Agreement or pursuant to applicable law, such shall not prejudice that party's rights to pursue any of those remedies at any future time and shall not constitute a waiver of rights. 24. Assignments. This Agreement is binding upon and shall inure to the benefit of the permitted successors or assigns of the respective parties hereto, except that neither party may assign its rights or obligations under this Agreement without the express written consent of the other (which consent shall not be unreasonably withheld). 25. Amendments. This Agreement shall not be amended or altered in any manner unless such amendment or alteration is in a writing signed by both parties. 26. Record-Keeping Requirements. To the extent required by the regulations promulgated by the Health Care Financing Administration pursuant to Section 952 of the Omnibus Reconciliation Act of 1980, GKF shall: - 11 - 12 (a) Until the expiration of four (4) years following the furnishing of services pursuant to this Agreement, GKF agrees to make available upon written request of the Secretary of Health and Human Services or the U.S. Comptroller General or any of their duly authorized representatives, this Agreement, any books, documents and records necessary to verify the nature and extent of costs incurred by Medical Center by reason of the activities of GKF under this Agreement; and (b) If GKF elects to delegate any of its duties under this Agreement (which have a cost or value of Ten Thousand Dollars ($10,000.00) or more over a twelve (12) month period) to a related organization, GKF may do so only through a subcontractor which is consented to by Medical Center, it being understood that, inasmuch as Medical Center is entering into this Agreement in reliance on GKF's reputation and expertise, that Medical Center shall be the sole judge of the reputation and expertise of the proposed delegee, and only through a subcontractor which provides that, until the expiration of four (4) years following the furnishing of services under such subcontract, the related organization shall make available, on request of the Secretary of Health and Human Services or the U.S. Comptroller General or any of their authorized representatives, the subcontract, and books, documents and records of the nature and extent of costs incurred by Medical Center by reason of activities of such related organization under such subcontract. No delegation by GKF of its duties hereunder shall relieve GKF from liability hereunder. 27. Miscellaneous Provisions. (a) The invalidity or unenforceability of any portion or provision of this Agreement shall not effect the validity or enforceability of any other portion, nor shall either party's implied or express consent to the breach or waiver of any provision of this Agreement constitute a waiver of such provision as to any subsequent breach. (b) In the event of any claim or controversy arising hereunder, the prevailing party in such claim or controversy shall be entitled to a reasonable attorneys' fee in addition to whatever other relief said party would be otherwise entitled. (c) Force Majeure. Failure to perform by either party will be excused in the event of any delay or inability to perform its duties under this Agreement directly or indirectly caused by conditions beyond its reasonable control including without limitation, fires, floods, earthquakes, snow, ice, disasters, Acts of God, accidents, riots, wars, operation of law, strikes, governmental action or regulations, shortages of labor, fuel, power, materials, manufacturer delays or transportation problems. - 12 - 13 IN WITNESS WHEREOF, the parties have signed this Agreement on the day and year first above written. Medical Center GK Financing, LLC By: /s/ William B. Petasnick By: /s/ Craig K. Tagawa -------------------------------- --------------------------------- President & CEO Chief Executive Officer Froedtert Memorial Lutheran Hospital - 13 - 14 Exhibit 1 PER PROCEDURE PAYMENTS
Annual Procedures Performed Fee Per Procedure - --------------------------- ----------------- * * * * * * * *
Note: Procedure counts will revert to zero on each anniversary of the Commencement Date. - 14 - EX-10.27 5 FROEDTERT - JUNE 24, 1999 1 Exhibit 10.27 FROEDTERT Memorial Lutheran Hospital June 24, 1999 Craig K. Tagawa Chief Executive Officer GK Financing, LLC Four Embarcadero Center Suite 3620 San Francisco, CA 94111-4155 Dear Craig: This letter serves as an addendum to our May 28, 1999 Lease Agreement for a Gamma Knife Unit between GK Financing and Froedtert Memorial Lutheran Hospital. It is my understanding that Charlie Runge and you agreed to the following term, to be added at the end of section 16: Prior to the designated termination date, Medical Center, upon notice to GKF, may elect to purchase the equipment for its fair market value or loan/lease payoff amount, whichever is higher. If you are in agreement with this language, please so indicate by signing both copies of this addendum and returning one to my office. Thank you. Very truly yours, FROEDTERT MEMORIAL LUTHERAN HOSPITAL /s/ Blaine J. O'Connell - ------------------------ Blaine J. O'Connell Sr. Vice President & CFO GK FINANCING, LLC By: /s/ Craig K. Tagawa ---------------------------------------- Craig C. Tagawa, Chief Executive Officer 9200 W Wisconsin Avenue P.O. Box 26099 Milwaukee, WI 53226-3596 414/259-3000 www.froedtert.com Primary affiliate of the Medical College of Wisconsin Member, Horizon Healthcare Inc. EX-10.28 6 FROEDTERT - JULY 12, 1999 1 Exhibit 10.28 FROEDTERT Memorial Lutheran Hospital July 12, 1999 Craig K. Tagawa Chief Executive Officer GK Financing, LLC Four Embarcadero Center Suite 3620 San Francisco, CA 94111-4155 Dear Craig: This letter serves to amend our May 28, 1999 Lease Agreement for a Gamma Knife Unit between GK Financing (GKF) and Froedtert Memorial Lutheran Hospital (FMLH). GKF and FMLH agree to change the delivery date identified in Section 4, from July 1, 1999 to October 15, 1999. All other provisions of the lease continue to apply, including the penalty provision for delivery more than 30 days after the amended delivery date. Please confirm this amendment by signing the enclosed copy of this letter and returning it to me. Very truly yours, FROEDTERT MEMORIAL LUTHERAN HOSPITAL /s/ Blaine J. O'Connell - ------------------------ Blaine J. O'Connell Sr. Vice President & CFO GK FINANCING, LLC /s/ Craig K. Tagawa - ---------------------------------------- Craig K. Tagawa, Chief Executive Officer cc: Charles W. Runge 9200 West Wisconsin Avenue P.O. Box 26099 Milwaukee, WI 53226-3596 Telephone: 414-259-3000 Staffed by physicians of the Medical College of Wisconsin. Member, Horizon Healthcare Inc. EX-10.29 7 FROEDTERT - AUGUST 24, 1999 1 Exhibit 10.29 FROEDTERT Memorial Lutheran Hospital August 24, 1999 Craig K. Tagawa Chief Executive Officer GK Financing, LLC Four Embarcadero Center, Suite 3620 San Francisco, CA 94111-4155 Dear Craig: This letter serves to amend our May 28, 1999 Lease Agreement for a Gamma Knife Unit between GK Financing, LLC (GKF) and Froedtert Memorial Lutheran Hospital (FMLH). GKF and FMLH agree to change the delivery date identified in Section 4, from July 1, 1999 to December 8, 1999. All other provisions of the lease continue to apply, including the penalty provision for delivery more than 30 days after the amended delivery date. This agreement supercedes our July 12, 1999 amendment letter, in which we agreed to change the delivery date from July 1, 1999 to October 15, 1999. Please confirm this amendment by signing the enclosed copy of this letter and returning it to me. Very truly yours, FROEDTERT MEMORIAL LUTHERAN HOSPITAL /s/ Blaine J. O'Connell - ------------------------ Blaine J. O'Connell Sr. Vice President & CFO GK FINANCING, LLC /s/ Craig K. Tagawa - ----------------------- Craig K. Tagawa Chief Executive Officer cc: Charles W. Runge 9200 W. Wisconsin Avenue P.O. Box 26099 Milwaukee, WI 53226-3596 414/259-3000 www.froedtert.com Primary affiliate of the Medical College of Wisconsin Member, Horizon Healthcare Inc. EX-21.0 8 LIST OF SUBSIDIARIES 1 Exhibit 21.0 The subsidiaries of American Shared Hospital Services are: American Shared Radiosurgery Services A California corporation GK Financing, LLC A California limited liability company OR21, Inc. A California corporation MMRI, Inc. A California corporation Embarcadero Transition Corp. III A California corporation European Shared Medical Services Limited An English registered company African American Church Health and Economic Services, Inc. A California corporation ACHES Insurance Services, Inc. A California corporation EX-23.1 9 CONSENT OF MOSS ADAMS, LLP 1 MOSS ADAMS LLP EXHIBIT 23.1 CONSENT OF INDEPENDENT AUDITORS We consent to the incorporation by reference in the Registration Statement, as amended, (Forms S-8, No. 2-90646; No. 33-21509; No. 33-48980) pertaining to the 1984 Stock Option Plan of American Shared Hospital Services; the Registration Statement (Form S-8, No. 33-45999) pertaining to the American Shared Hospital Services 1991 Employee Stock Bonus Plan; the Registration Statement (Form S-8, No. 333-08009) pertaining to the 1995 Stock Option Plan of American Shared Hospital Services; the Registration Statement, as amended, (Form S-3, No. 333-12879) pertaining to the registration of 2,679,047 Common Shares of American Shared Hospital Services; and the Registration Statement, as amended, (Form S-3, No. 33-63721) pertaining to the registration of 1,290,853 Common Shares of American Shared Hospital Services and 441,147 Warrants to purchase Common Shares of American Shared Hospital Services and in the related Prospectuses of our report dated February 18, 2000, with respect to the consolidated financial statements and schedule of American Shared Hospital Services included in this Annual Report (Form 10-K) for the year ended December 31, 1999. /s/ Moss Adams LLP March 29, 2000 Stockton, California EX-23.2 10 CONSENT OF GRANT THORNTON, LLP 1 EXHIBIT 23.2 CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS We have issued our report dated March 12, 1999, accompanying the 1998 consolidated financial statements and schedule included in the Annual Report of American Shared Hospital Services on Form 10-K for the year ended December 31, 1999. We hereby consent to the incorporation by reference of said report in the Registration Statements of American Shared Hospital Services on Forms S-3 (File No. 333-12879 and File No. 333-63721) and on Forms S-8 (File Nos. 2-90646; 33-21509; 33-48980, 33-45999, and 333-08009). /s/ GRANT THORNTON LLP San Jose, California March 27, 2000 EX-23.3 11 CONSENT OF ERNST & YOUNG, LLP 1 EXHIBIT 23.3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS We consent to the incorporation by reference in the Registration Statement Forms S-3 (File No. 33-12879 and File No. 333-63721) and on Forms S-8 (File Nos. 2-90646, 33-21509, 33-48980, 33-45999, and 333-08009) of American Shared Hospital Services and in the related Prospectus of our report dated February 27, 1998, with respect to the consolidated financial statements and schedules of American Shared Hospital Services included in this Annual Report (Form 10-K) for the year ended December 31, 1999. /s/ ERNST & YOUNG LLP March 27, 2000 Walnut Creek, California EX-27 12 FINANCIAL DATA SCHEDULE
5 THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED FINANCIAL STATEMENTS OF AMERICAN SHARED HOSPITAL SERVICES FOR THE PERIOD ENDED DECEMBER 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. 12-MOS DEC-31-1999 JAN-01-1999 DEC-31-1999 12,953 0 1,226 0 0 14,695 27,453 (5,397) 36,986 3,570 19,887 0 0 10,036 3,231 36,986 7,156 7,156 0 2,165 1,803 0 1,309 1,991 (716) 2,707 0 0 0 2,707 .68 .48
-----END PRIVACY-ENHANCED MESSAGE-----